| 1 |
Coutinho DF, Mundi PS, Marks LJ, Burke C, Ortiz MV, Diolaiti D, Bird L, Vallance KL, Ibáñez G, You D, Long M, Rosales N, Grunn A, Ndengu A, Siddiquee A, Gaviria ES, Rainey AR, Fazlollahi L, Hosoi H, Califano A, Kung AL, Dela Cruz FS. Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors. Med (N Y) 2022;3:774-791.e7. [PMID: 36195086 DOI: 10.1016/j.medj.2022.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Kari S, Subramanian K, Altomonte IA, Murugesan A, Yli-Harja O, Kandhavelu M. Programmed cell death detection methods: a systematic review and a categorical comparison. Apoptosis 2022. [PMID: 35713779 DOI: 10.1007/s10495-022-01735-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Izutsu M, Domoto T, Kamoshida S, Ohsaki H, Matsuoka H, Umeki Y, Shiogama K, Hirayama M, Suda K, Uyama I. Expression status of p53 and organic cation transporter 1 is correlated with poor response to preoperative chemotherapy in esophageal squamous cell carcinoma. World J Surg Oncol 2022;20:105. [PMID: 35365176 DOI: 10.1186/s12957-022-02571-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Mukherjee K, Sur D, Singh A, Rai S, Das N, Sekar R, Narindi S, Dhingra VK, Jat B, Balraam KVV, Agarwal SP, Mandal PK. Robust expression of LINE-1 retrotransposon encoded proteins in oral squamous cell carcinoma. BMC Cancer 2021;21:628. [PMID: 34044801 DOI: 10.1186/s12885-021-08174-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 5 |
Mukherjee K, Sur D, Singh A, Rai S, Das N, Narindi S, Sekar R, Dhingra VK, Jat B, Balraam KVV, Agarwal SP, Mandal PK. Robust expression of LINE-1 retrotransposon encoded proteins in oral squamous cell carcinoma.. [DOI: 10.1101/2020.11.24.395285] [Reference Citation Analysis]
|
| 6 |
Zanelli M, Ciarrocchi A, De Petris G, Zizzo M, Costantini M, Bisagni A, Torricelli F, Nicoli D, Ramundo D, Ricci S, Palicelli A, Sanguedolce F, Ascani S, Castro Ruiz C, Annessi V, Zamponi R, Bortesi M, Martino V, Marchetti M, De Marco L. Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study. Cancers (Basel) 2020;12. [PMID: 32917028 DOI: 10.3390/cancers12092571] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Aydin AM, Chahoud J, Adashek JJ, Azizi M, Magliocco A, Ross JS, Necchi A, Spiess PE. Understanding genomics and the immune environment of penile cancer to improve therapy. Nat Rev Urol 2020;17:555-70. [DOI: 10.1038/s41585-020-0359-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 8 |
Bignold LP. Typing, grading, and staging of cases of tumor. Principles of Tumors 2020. [DOI: 10.1016/b978-0-12-816920-9.00010-9] [Reference Citation Analysis]
|
| 9 |
Xue Y, San Luis B, Lane DP. Intratumour heterogeneity of p53 expression; causes and consequences. J Pathol 2019;249:274-85. [PMID: 31322742 DOI: 10.1002/path.5328] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 10 |
Karner KH, Kohan JL, Tripp SR, Salama ME. Characterization of myeloid malignancies with TP53 mutations and comparison to P53 expression by immunohistochemical staining methods. Int J Lab Hematol 2020;42:e35-7. [PMID: 31390152 DOI: 10.1111/ijlh.13088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 11 |
Nikolova D, Chalovska-Ivanova V, Genadieva-Dimitrova M, Eftimov A, Jovanovik R, Janevska V. TP53 Mutation in Correlation to Immunohistochemical Expression of P53 Protein in Patients with Hepatocellular Carcinoma. Open Access Maced J Med Sci 2018;6:1181-6. [PMID: 30087719 DOI: 10.3889/oamjms.2018.278] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 12 |
Vital D, Huber GF, Holzmann D, Moch H, Ikenberg K. The presence of aberrant p53 pattern is a negative prognostic predictor in squamous cell carcinoma of the nasal vestibule. Eur Arch Otorhinolaryngol 2017;274:3503-12. [PMID: 28669050 DOI: 10.1007/s00405-017-4659-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Bodoor K, Al-ghabkari A, Matalka I, Haddad Y, Alkhateeb A, Jaradat S, Jaradat ZW, Al-ghazo M, Abu-sheikha A, Jalboush SA, Jarun Y. Assessment of p53 mutations, expression and prognosis in bladder cancer patients from Jordan: Identification of novel deletion mutations in the DNA-binding domain. Meta Gene 2017;12:33-42. [DOI: 10.1016/j.mgene.2017.01.002] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 14 |
Georgakilas AG, Martin OA, Bonner WM. p21: A Two-Faced Genome Guardian. Trends Mol Med. 2017;23:310-319. [PMID: 28279624 DOI: 10.1016/j.molmed.2017.02.001] [Cited by in Crossref: 266] [Cited by in F6Publishing: 284] [Article Influence: 44.3] [Reference Citation Analysis]
|
| 15 |
Rodrigues VDC, Comin CH, Soares JC, Soares AC, Melendez ME, Fregnani JHTG, Carvalho AL, Costa LDF, Oliveira ON. Analysis of Scanning Electron Microscopy Images To Investigate Adsorption Processes Responsible for Detection of Cancer Biomarkers. ACS Appl Mater Interfaces 2017;9:5885-90. [DOI: 10.1021/acsami.6b16105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 16 |
Mcconechy MK, Lee C, Clarke BA. Uterine Clear Cell Carcinoma. Molecular Pathology Library 2017. [DOI: 10.1007/978-3-319-57985-6_6] [Reference Citation Analysis]
|
| 17 |
Mahmoudzadeh Sagheb H, Heidari Z, Jahantigh M, Narouei M. Immunohistochemical Expression of p53 and Ki-67 Genes in Gastric Cancer and Precancerous Lesions in the Patients with Helicobacter pylori Infection. Gene Cell Tissue 2016;3. [DOI: 10.17795/gct-41341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 18 |
Hassan CE, Webster TJ. The effect of red-allotrope selenium nanoparticles on head and neck squamous cell viability and growth. Int J Nanomedicine 2016;11:3641-54. [PMID: 27536104 DOI: 10.2147/IJN.S105173] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 19 |
Evangelou K, Galanos P, Gorgoulis VG. The Janus face of p21. Mol Cell Oncol 2016;3:e1215776. [PMID: 27857977 DOI: 10.1080/23723556.2016.1215776] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 20 |
Robbins P. p53 and Breast Cancer. Int J Surg Pathol 1996;4:93-110. [DOI: 10.1177/106689699600400206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 21 |
Imazawa T, Nishikawa A, Toyoda K, Furukawa F, Mitsui M, Hirose M. Sequential Alteration of Apoptosis, p53 Expression, and Cell Proliferation in the Rat Pancreas Treated with 4-Hydroxyaminoquinoline 1-Oxide. Toxicol Pathol 2003;31:625-31. [DOI: 10.1080/01926230390241855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 22 |
Perz E, Kuhn JG. Review : p53 in the pathogenesis, diagnosis, and treatment of cancer. J Oncol Pharm Pract 1998;4:75-102. [DOI: 10.1177/107815529800400201] [Reference Citation Analysis]
|
| 23 |
Zeggai S, Harir N, Tou A, Sellam F, Mrabent MN, Salah R. Immunohistochemistry and scoring of Ki-67 proliferative index and p53 expression in gastric B cell lymphoma from Northern African population: a pilot study. J Gastrointest Oncol 2016;7:462-8. [PMID: 27284480 DOI: 10.21037/jgo.2016.01.01] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 24 |
Goh AM, Xue Y, Leushacke M, Li L, Wong JS, Chiam PC, Rahmat SA, Mann MB, Mann KM, Barker N, Lozano G, Terzian T, Lane DP. Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice. Oncotarget 2015;6:17968-80. [PMID: 26255629 DOI: 10.18632/oncotarget.4956] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 25 |
Dave KV, Chalishazar M, Dave VR, Panja P, Singh M, Modi TG. Immunohistochemical expression of p53 and its clinicopathological correlation with modified Anneroth's histological grading system. J Oral Maxillofac Pathol 2016;20:29-35. [PMID: 27194859 DOI: 10.4103/0973-029X.180922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 26 |
Venkateswaran SP, Nathan LE, Mutalik VS, Shamsuddin NH. Argyrophilic nuclear organizer region and p73 expression in head and neck squamous cell carcinomas: Teammates or adversaries? J Oral Maxillofac Pathol 2016;20:427-35. [PMID: 27721608 DOI: 10.4103/0973-029X.190945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 27 |
Hayes SA, Pandiri AR, Ton TV, Hong HH, Clayton NP, Shockley KR, Peddada SD, Gerrish K, Wyde M, Sills RC, Hoenerhoff MJ. Renal Cell Carcinomas in Vinylidene Chloride-exposed Male B6C3F1 Mice Are Characterized by Oxidative Stress and TP53 Pathway Dysregulation. Toxicol Pathol 2016;44:71-87. [PMID: 26682919 DOI: 10.1177/0192623315610820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 28 |
Meleis MH, El-agwany AMS. Tubal Precursor Lesions for High-Grade Serous Ovarian Carcinoma. Indian J Gynecol Oncolog 2015;13:22. [DOI: 10.1007/s40944-015-0031-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 29 |
Horvath B, Singh P, Xie H, Thota PN, Sun X, Liu X. Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett’s esophagus and epithelial changes indefinite for dysplasia. Gastroenterol Rep (Oxf). 2015; Epub ahead of print. [PMID: 26486567 DOI: 10.1093/gastro/gov045] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 30 |
Vici P, Sperati F, Maugeri-Saccà M, Melucci E, Di Benedetto A, Di Lauro L, Pizzuti L, Sergi D, Terrenato I, Esposito L, Iannuzzi CA, Pasquale R, Botti C, Fuhrman B, Giordano A, Mottolese M, Barba M. p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab. Oncotarget 2014;5:10382-92. [PMID: 25071015 DOI: 10.18632/oncotarget.2060] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 31 |
Pavlisko EN, Roggli VL. Diseases of the serosal surfaces. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015. [DOI: 10.1017/9781139137201.020] [Reference Citation Analysis]
|
| 32 |
Chua JS, Liew HP, Guo L, Lane DP. Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish. Oncogene 2015;34:5933-41. [PMID: 25746004 DOI: 10.1038/onc.2015.57] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 33 |
Bignold LP. Molecular Abnormalities in Tumors. Principles of Tumors 2015. [DOI: 10.1016/b978-0-12-801565-0.00009-3] [Reference Citation Analysis]
|
| 34 |
Ando K, Oki E, Saeki H, Yan Z, Tsuda Y, Hidaka G, Kasagi Y, Otsu H, Kawano H, Kitao H, Morita M, Maehara Y. Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer. Cancer Med. 2015;4:75-83. [PMID: 25354498 DOI: 10.1002/cam4.346] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 35 |
Tsai JH, Liau JY, Lin YL, Lin LI, Cheng YC, Cheng ML, Jeng YM. Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis. Mod Pathol 2014;27:1375-85. [PMID: 24603588 DOI: 10.1038/modpathol.2014.35] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 36 |
Sajeevan TP, Saraswathi TR, Ranganathan K, Joshua E, Rao UD. Immunohistochemical study of p53 and proliferating cell nuclear antigen expression in odontogenic keratocyst and periapical cyst. J Pharm Bioallied Sci. 2014;6:S52-S57. [PMID: 25210385 DOI: 10.4103/0975-7406.137388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 37 |
Bouchalova P, Nenutil R, Muller P, Hrstka R, Appleyard MV, Murray K, Jordan LB, Purdie CA, Quinlan P, Thompson AM, Vojtesek B, Coates PJ. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status. J Pathol 2014;233:238-46. [PMID: 24687952 DOI: 10.1002/path.4356] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 38 |
Soussi T, Leroy B, Taschner PE. Recommendations for analyzing and reporting TP53 gene variants in the high-throughput sequencing era. Hum Mutat 2014;35:766-78. [PMID: 24729566 DOI: 10.1002/humu.22561] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 39 |
Heaton CM, Durr ML, Tetsu O, van Zante A, Wang SJ. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma. Laryngoscope 2014;124:E267-73. [PMID: 24431303 DOI: 10.1002/lary.24595] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 40 |
Nasif WA, Mukhtar MH, El-emshaty HM, Al-bukhari TA. Evaluation of circulating TP53 antigen in the sera of gastric cancer patients: As a tumor marker. Biomarkers and Genomic Medicine 2013;5:175-80. [DOI: 10.1016/j.bgm.2013.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 41 |
Wang X, Sheng P, Guo X, Wang J, Hou L, Hu G, Luo C, Dong Y, Lu Y. Identification and expression of a novel MDM4 splice variant in human glioma. Brain Research 2013;1537:260-6. [DOI: 10.1016/j.brainres.2013.07.054] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 42 |
Brachova P, Thiel KW, Leslie KK. The consequence of oncomorphic TP53 mutations in ovarian cancer. Int J Mol Sci 2013;14:19257-75. [PMID: 24065105 DOI: 10.3390/ijms140919257] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 43 |
Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Karashima R, Imamura Y, Ida S, Ishimoto T, Iwagami S. p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma. Med Oncol. 2013;30:728. [PMID: 24026664 DOI: 10.1007/s12032-013-0728-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 44 |
Neto PD, Alchorne M, Michalany N, Abreu M, Borra R. Reduced P53 Staining in Actinic Keratosis is Associated with Squamous Cell Carcinoma: A Preliminary Study. Indian J Dermatol 2013;58:325. [PMID: 23919015 DOI: 10.4103/0019-5154.113935] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 45 |
Coates PJ. Molecular Biology—Changing Our Profession. Journal of Histotechnology 2013;17:191-3. [DOI: 10.1179/his.1994.17.3.191] [Reference Citation Analysis]
|
| 46 |
Lee J, Myung S, Song Y. Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: A meta-analysis of observational studies. Gynecologic Oncology 2013;129:613-9. [DOI: 10.1016/j.ygyno.2013.02.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 47 |
Abdelmoula-souissi S, Zouari N, Miladi-abdenadher I, Yaich-kolsi O, Ayadi-masmoudi I, Khabir A, Masmoudi H, Frikha M, Mokdad-gargouri R. Secreted recombinant P53 protein from Pichia pastoris is a useful antigen for detection of serum p53: autoantibody in patients with advanced colorectal adenocarcinoma. Mol Biol Rep 2013;40:3865-72. [DOI: 10.1007/s11033-012-2467-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 48 |
Zhang SS, Huang QY, Yang H, Xie X, Luo KJ, Wen J, Cai XL, Yang F, Hu Y, Fu JH. Correlation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: a meta-analysis. Ann Surg Oncol. 2013;20:2419-2427. [PMID: 23515910 DOI: 10.1245/s10434-012-2859-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 49 |
Kreahling JM, Foroutan P, Reed D, Martinez G, Razabdouski T, Bui MM, Raghavan M, Letson D, Gillies RJ, Altiok S. Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas. PLoS One 2013;8:e57523. [PMID: 23520471 DOI: 10.1371/journal.pone.0057523] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 50 |
Visioli F, Lauxen IS, Sant'ana Filho M, Rados PV. Expression of the cell cycle regulation proteins p53 and p21WAF1 in different types of non-dysplastic leukoplakias. J Appl Oral Sci 2012;20:369-75. [PMID: 22858706 DOI: 10.1590/s1678-77572012000300013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 51 |
Gadbail AR, Patil R, Chaudhary M. Co-expression of Ki-67 and p53 protein in ameloblastoma and keratocystic odontogenic tumor. Acta Odontol Scand 2012;70:529-35. [PMID: 21780975 DOI: 10.3109/00016357.2011.600714] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 52 |
Francis G, Dileep Kumar U, Nalinakumari K, Jayasree K, Kannan S. Accumulation of inactive p53 protein in oral squamous cell carcinoma: stabilization by protein interaction. Eur J Oral Sci 2013;121:21-8. [DOI: 10.1111/eos.12007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 53 |
Zacchetti A, van Garderen E, Rutteman GR. Immunohistochemical evaluation of p53 expression with different antibodies in malignant canine tumours with or without p53 gene mutation. Vet Comp Oncol 2007;5:108-18. [PMID: 19754794 DOI: 10.1111/j.1476-5829.2006.00120.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 54 |
Friedrich MG, Schwaibold H, Wintzer O, Pichlmeier U, Huland H. p53 in noncancerous bladder mucosa as a marker of disease recurrence in patients with superficial transitional cell carcinoma of the bladder. Urol Oncol 1997;3:125-31. [PMID: 21227117 DOI: 10.1016/s1078-1439(98)00018-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 55 |
Ciancio N, Galasso MG, Campisi R, Bivona L, Migliore M, Di Maria GU. Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer. Multidiscip Respir Med 2012;7:29. [PMID: 22978804 DOI: 10.1186/2049-6958-7-29] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 56 |
Al-Kashwan TA, Houshmand M, Al-Janabi A, Melconian AK, Al-Abbasi D, Al-Musawi MN, Rostami M, Yasseen AA. Specific-mutational patterns of p53 gene in bladder transitional cell carcinoma among a group of Iraqi patients exposed to war environmental hazards. BMC Res Notes. 2012;5:466. [PMID: 22929185 DOI: 10.1186/1756-0500-5-466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 57 |
Chatterjee M, Tainsky MA. Autoantibodies as biomarkers for ovarian cancer. Cancer Biomark 2010-2011;8:187-201. [PMID: 22045353 DOI: 10.3233/CBM-2011-0213] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 58 |
Warrick J, Luo J, Robirds D, Branson J, Frater JL, Kreisel F, Hassan A, Nguyen TT. Gastrointestinal lymphomas in a North American population: clinicopathologic features from one major Central-Midwestern United States tertiary care medical center. Diagn Pathol. 2012;7:76. [PMID: 22742986 DOI: 10.1186/1746-1596-7-76] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 59 |
Yemelyanova A, Vang R, Kshirsagar M, Lu D, Marks MA, Shih IeM, Kurman RJ. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol 2011;24:1248-53. [PMID: 21552211 DOI: 10.1038/modpathol.2011.85] [Cited by in Crossref: 338] [Cited by in F6Publishing: 355] [Article Influence: 28.2] [Reference Citation Analysis]
|
| 60 |
Bond CE, Umapathy A, Ramsnes I, Greco SA, Zhen Zhao Z, Mallitt KA, Buttenshaw RL, Montgomery GW, Leggett BA, Whitehall VL. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers. Int J Cancer 2012;130:1567-76. [PMID: 21557216 DOI: 10.1002/ijc.26175] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 61 |
Donzelli S, Biagioni F, Fausti F, Strano S, Fontemaggi G, Blandino G. Oncogenomic Approaches in Exploring Gain of Function of Mutant p53. Curr Genomics 2008;9:200-7. [PMID: 19440517 DOI: 10.2174/138920208784340713] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 62 |
Kang SM, Koh W, Suh GY, Chung MP, Han J, Kim H, Kwon OJ, Um S. Association of p53 Expression with Metabolic Features of Stage I Non-Small Cell Lung Cancer. Tuberc Respir Dis 2011;71:417. [DOI: 10.4046/trd.2011.71.6.417] [Reference Citation Analysis]
|
| 63 |
Gonçalves AR, Carneiro AJ, Martins I, de Faria PA, Ferreira MA, de Mello EL, Fogaça HS, Elia CC, de Souza HS. Prognostic significance of p53 protein expression in early gastric cancer. Pathol Oncol Res 2011;17:349-55. [PMID: 21116760 DOI: 10.1007/s12253-010-9333-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 64 |
Piura E, Piura B. Autoantibodies to tumor-associated antigens in breast carcinoma. J Oncol 2010;2010:264926. [PMID: 21113302 DOI: 10.1155/2010/264926] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 65 |
Goebell PJ, Knowles MA. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Urol Oncol 2010;28:409-28. [PMID: 20610279 DOI: 10.1016/j.urolonc.2010.04.003] [Cited by in Crossref: 128] [Cited by in F6Publishing: 137] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 66 |
Karakok M, Turkmen A, Bekerecioglu M, Emrah Koçer N. Immunohistochemical prognostic criteria in xeroderma pigmentosum: Immunohistochemistry in Xeroderma Pigmentosum. International Journal of Dermatology 2010;49:1266-71. [DOI: 10.1111/j.1365-4632.2009.04382.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 67 |
Fratila O, Ilias T, Puscasiu D. The value of histological changes and immunohistochemical markers Ki67 and p53 in the assessment of ulcerative colitis related dysplasia. Open Medicine 2010;5:417-25. [DOI: 10.2478/s11536-009-0085-7] [Reference Citation Analysis]
|
| 68 |
Webster JD, Dennis MM, Dervisis N, Heller J, Bacon NJ, Bergman PJ, Bienzle D, Cassali G, Castagnaro M, Cullen J, Esplin DG, Peña L, Goldschmidt MH, Hahn KA, Henry CJ, Hellmén E, Kamstock D, Kirpensteijn J, Kitchell BE, Amorim RL, Lenz SD, Lipscomb TP, Mcentee M, Mcgill LD, Mcknight CA, Mcmanus PM, Moore AS, Moore PF, Moroff SD, Nakayama H, Northrup NC, Sarli G, Scase T, Sorenmo K, Schulman FY, Shoieb AM, Smedley RC, Spangler WL, Teske E, Thamm DH, Valli VE, Vernau W, Euler HV, Withrow SJ, Weisbrode SE, Yager J, Kiupel M. Recommended Guidelines for the Conduct and Evaluation of Prognostic Studies in Veterinary Oncology. Vet Pathol 2011;48:7-18. [DOI: 10.1177/0300985810377187] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 69 |
Calazans SG, Rodigheri SM, Fernandes SC, Amorim RL, Sequeira JL, Sena JAD, Daleck CR. Imunorreatividade da p53 associada à ausência de mutações no gene TP53 em linfomas caninos. Cienc Rural 2010;40:1444-1447. [DOI: 10.1590/s0103-84782010000600034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 70 |
Goebell P, Keck B, Wach S, Wullich B. Stellenwert von Biomarkern in der Urologie. Urologe 2010;49:547-59. [DOI: 10.1007/s00120-010-2286-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 71 |
Piura B, Piura E. Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma. J Oncol 2009;2009:581939. [PMID: 20145720 DOI: 10.1155/2009/581939] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 72 |
Wang YP, Liu BY. High expression of osteopontin and CD44v6 in odontogenic keratocysts. J Formos Med Assoc 2009;108:286-92. [PMID: 19369175 DOI: 10.1016/S0929-6646(09)60068-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 73 |
Szybka M, Zakrzewska M, Rieske P, Pasz-Walczak G, Kulczycka-Wojdala D, Zawlik I, Stawski R, Jesionek-Kupnicka D, Liberski PP, Kordek R. cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer. BMC Cancer 2009;9:278. [PMID: 19671129 DOI: 10.1186/1471-2407-9-278] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 74 |
Custodio AB, González-larriba JL, Bobokova J, Calles A, Álvarez R, Cuadrado E, Manzano A, Díaz-rubio E. Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early-Stage Non-small Cell Lung Cancer. Journal of Thoracic Oncology 2009;4:891-910. [DOI: 10.1097/jto.0b013e3181a4b8fb] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 75 |
Gadbail AR, Chaudhary M, Patil S, Gawande M. Actual Proliferating Index and p53 protein expression as prognostic marker in odontogenic cysts. Oral Dis 2009;15:490-8. [PMID: 19563416 DOI: 10.1111/j.1601-0825.2009.01590.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 76 |
Wang Y, Liu B. Expression of osteopontin and its receptors in ameloblastomas. Oral Oncology 2009;45:538-42. [DOI: 10.1016/j.oraloncology.2008.07.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 77 |
Prior SL, Griffiths AP, Lewis PD. A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer. Br J Dermatol 2009;161:1067-71. [PMID: 19624548 DOI: 10.1111/j.1365-2133.2009.09304.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 78 |
de Freitas Mda C, Ramalho LM, Xavier FC, Moreira AL, Reis SR. p53 and MDM2 protein expression in actinic cheilitis. J Appl Oral Sci 2008;16:414-9. [PMID: 19082401 DOI: 10.1590/s1678-77572008000600011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 79 |
Karim S, Ali A. Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India. World J Gastroenterol 2009; 15(11): 1381-1387 [PMID: 19294769 DOI: 10.3748/wjg.15.1381] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 80 |
Sorensen FB, Jensen K, Vaeth M, Hager H, Funder AM, Safwat A, Keller J, Christensen M. Immunohistochemical Estimates of Angiogenesis, Proliferative Activity, p53 Expression, and Multiple Drug Resistance Have No Prognostic Impact in Osteosarcoma: A Comparative Clinicopathological Investigation. Sarcoma 2008;2008:874075. [PMID: 19266050 DOI: 10.1155/2008/874075] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 81 |
Meng G, Zhang H, Bu H, Geng J. Low-grade fibromyxoid sarcoma versus fibromatosis: A comparative study of clinicopathological and immunohistochemical features. Diagn Cytopathol 2009;37:96-102. [DOI: 10.1002/dc.20967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 82 |
Lopes CV, Mnif H, Pesenti C, Bories E, Monges G, Giovannini M. p53 and Ki-67 in Barrett's carcinoma: is there any value to predict recurrence after circumferential endoscopic mucosal resection? Arq Gastroenterol 2007;44:304-8. [PMID: 18317648 DOI: 10.1590/s0004-28032007000400005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 83 |
Attallah AM, Shiha GE, Ismail H, Mansy SE, El-Sherbiny R, El-Dosoky I. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection. Clin Biochem. 2009;42:455-461. [PMID: 19063876 DOI: 10.1016/j.clinbiochem.2008.11.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 84 |
Terzian T, Suh YA, Iwakuma T, Post SM, Neumann M, Lang GA, Van Pelt CS, Lozano G. The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss. Genes Dev 2008;22:1337-44. [PMID: 18483220 DOI: 10.1101/gad.1662908] [Cited by in Crossref: 271] [Cited by in F6Publishing: 286] [Article Influence: 18.1] [Reference Citation Analysis]
|
| 85 |
Um S, Kim H, Kwon OJ, Han J, Shim YM. Prognostic Value of p53 Overexpression in Patients with Pathologic Stage I Non-small Cell Lung Cancer. Tuberc Respir Dis 2008;65:487. [DOI: 10.4046/trd.2008.65.6.487] [Reference Citation Analysis]
|
| 86 |
Cha J, Cho T, Park T, So J, Choi S, Park E. Analysis of expression of survivin, caspase 3, and p53 protein in cervical neoplasia comparing with Ki-67 index. Korean J Gynecol Oncol 2008;19:17. [DOI: 10.3802/kjgo.2008.19.1.17] [Reference Citation Analysis]
|
| 87 |
Kerr KM, Fraire AE. Preinvasive Disease. Dail and Hammar’s Pulmonary Pathology 2008. [DOI: 10.1007/978-0-387-72114-9_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 88 |
Jane EP, Premkumar DR, Pollack IF. AG490 influences UCN-01-induced cytotoxicity in glioma cells in a p53-dependent fashion, correlating with effects on BAX cleavage and BAD phosphorylation. Cancer Lett 2007;257:36-46. [PMID: 17900801 DOI: 10.1016/j.canlet.2007.06.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 89 |
Real FX. p53: it has it all, but will it make it to the clinic as a marker in bladder cancer? J Clin Oncol 2007;25:5341-4. [PMID: 18048811 DOI: 10.1200/JCO.2007.13.1904] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 90 |
Graesslin O, Chantot-bastaraud S, Lorenzato M, Birembaut P, Quéreux C, Daraï E. Fluorescence in situ Hybridization and Immunohistochemical Analysis of p53 Expression in Endometrial Cancer: Prognostic Value and Relation to Ploidy. Ann Surg Oncol 2008;15:484-92. [DOI: 10.1245/s10434-007-9712-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 91 |
Tsao MS, Aviel-Ronen S, Ding K, Lau D, Liu N, Sakurada A, Whitehead M, Zhu CQ, Livingston R, Johnson DH, Rigas J, Seymour L, Winton T, Shepherd FA. Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer. J Clin Oncol 2007;25:5240-7. [PMID: 18024870 DOI: 10.1200/JCO.2007.12.6953] [Cited by in Crossref: 228] [Cited by in F6Publishing: 252] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 92 |
Partridge M, Costea D, Huang X. The changing face of p53 in head and neck cancer. International Journal of Oral and Maxillofacial Surgery 2007;36:1123-38. [DOI: 10.1016/j.ijom.2007.06.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 93 |
Pablo Rodrigo J, Cabanillas R, Secades P, Canel M, Dolores Chiara M, Suárez C. Relación entre la expresión de FAK y p53 en los carcinomas epidermoides de laringe. Acta Otorrinolaringológica Española 2007;58:347-351. [DOI: 10.1016/s0001-6519(07)74943-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 94 |
Nijhof JG, Mulder AM, Speksnijder EN, Hoogervorst EM, Mullenders LH, de Gruijl FR. Growth stimulation of UV-induced DNA damage retaining epidermal basal cells gives rise to clusters of p53 overexpressing cells. DNA Repair (Amst) 2007;6:1642-50. [PMID: 17644448 DOI: 10.1016/j.dnarep.2007.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 95 |
Cabanillas R, Rodrigo JP, Astudillo A, Domínguez F, Suárez C, Chiara MD. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question. Cancer 2007;109:1791-8. [PMID: 17380529 DOI: 10.1002/cncr.22646] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 96 |
Ihrler S, Weiler C, Hirschmann A, Sendelhofert A, Lang S, Guntinas-Lichius O, Arnold G, Zietz C, Harrison JD. Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53. Histopathology 2007;51:362-71. [PMID: 17593217 DOI: 10.1111/j.1365-2559.2007.02736.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 97 |
Soussi T. p53 alterations in human cancer: more questions than answers. Oncogene. 2007;26:2145-2156. [PMID: 17401423 DOI: 10.1038/sj.onc.1210280] [Cited by in Crossref: 167] [Cited by in F6Publishing: 174] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 98 |
Strianese D, Baldi G, Staibano S, Baldi A, De Rosa G, Tranfa F, Bonavolontà G. Expression of apoptosis-related markers in malignant epithelial tumours of the lacrimal gland and their relation to clinical outcome. Br J Ophthalmol 2007;91:1239-43. [PMID: 17431014 DOI: 10.1136/bjo.2007.118661] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 99 |
Peltonen J, Welsh JA, Vähäkangas KH. Is there a role for PCR-SSCP among the methods for missense mutation detection of TP53 gene? Hum Exp Toxicol 2007;26:9-18. [PMID: 17334176 DOI: 10.1177/0960327107071918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 100 |
Kamoshida S, Suzuki M, Shimomura R, Sakurai Y, Komori Y, Uyama I, Tsutsumi Y. Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer. Br J Cancer 2007;96:277-83. [PMID: 17211470 DOI: 10.1038/sj.bjc.6603546] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 101 |
Shin JW, Lee SH, Park ES. Expression of Caspase 3, Survivin, and p53 Protein in Urethane Induced Mouse Lung Carcinogenesis. Tuberc Respir Dis 2007;63:251. [DOI: 10.4046/trd.2007.63.3.251] [Reference Citation Analysis]
|
| 102 |
Rodrigo JP, Cabanillas R, Secades P, Canel M, Chiara MD, Suárez C. Relationship Between FAK and P53 Expression in Squamous Cell Carcinomas of the Larynx. Acta Otorrinolaringologica (English Edition) 2007;58:347-51. [DOI: 10.1016/s2173-5735(07)70365-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 103 |
Soussi T. Analysis of p53 Gene Alterations in Cancer: A Critical View. 25 Years of p53 Research 2007. [DOI: 10.1007/978-1-4020-2922-6_12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 104 |
Rimm DL. What brown cannot do for you. Nat Biotechnol 2006;24:914-6. [PMID: 16900128 DOI: 10.1038/nbt0806-914] [Cited by in Crossref: 101] [Cited by in F6Publishing: 104] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 105 |
Walker RA. Quantification of immunohistochemistry?issues concerning methods, utility and semiquantitative assessment I. Histopathology 2006;49:406-10. [DOI: 10.1111/j.1365-2559.2006.02514.x] [Cited by in Crossref: 223] [Cited by in F6Publishing: 240] [Article Influence: 13.1] [Reference Citation Analysis]
|
| 106 |
Nemes JA, Deli L, Nemes Z, Márton IJ. Expression of p16INK4A, p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2006;102:344-52. [DOI: 10.1016/j.tripleo.2005.10.069] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 107 |
Neto Pimentel DR, Michalany N, Alchorne M, Abreu M, Borra RC, Weckx L. Actinic cheilitis: histopathology and p53. J Cutan Pathol 2006;33:539-44. [DOI: 10.1111/j.1600-0560.2006.00440.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 108 |
Schrier BP, Vriesema JL, Witjes JA, Kiemeney LA, Schalken JA. The Predictive Value of p53, p27Kip1, and α-Catenin for Progression in Superficial Bladder Carcinoma. European Urology 2006;50:76-82. [DOI: 10.1016/j.eururo.2005.12.041] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 109 |
Howe JR. Molecular Markers as a Tool for the Early Diagnosis of Pancreatic Cancer. M. D. Anderson Solid Tumor Oncology Series. [DOI: 10.1007/0-387-21600-6_3] [Reference Citation Analysis]
|
| 110 |
Kelley ST, Coppola D, Yeatman T, Marcet J. Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways. Clin Colorectal Cancer 2005;5:114-8. [PMID: 16098252 DOI: 10.3816/ccc.2005.n.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 111 |
Hall PA, McCluggage WG. Assessing p53 in clinical contexts: unlearned lessons and new perspectives. J Pathol 2006;208:1-6. [PMID: 16331594 DOI: 10.1002/path.1913] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 112 |
Westhof G, Olbrecht M, Wolff M, Schiermeier S, Zimmermann RC, Hatzmann W. Testing of Functional Integrity of p53 Protein in Primary Breast Cancer by a Rapid Quantitative p53-p21<sup>WAF1</sup> Double Assay May Improve the Clinical Value of p53. Tumor Biol 2006;27:252-260. [DOI: 10.1159/000094706] [Reference Citation Analysis]
|
| 113 |
Akahane T, Sekizawa A, Okuda T, Kushima M, Saito H, Okai T. Disappearance of steroid hormone dependency during malignant transformation of ovarian clear cell cancer. Int J Gynecol Pathol 2005;24:369-76. [PMID: 16175084 DOI: 10.1097/01.pgp.0000165173.90339.a2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 114 |
Isolan GR, Ribas Filho JM, Isolan PM, Giovanini A, Malafaia O, Dini LI, Kummer A Jr, Negrão AW. [Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins]. Arq Neuropsiquiatr 2005;63:997-1004. [PMID: 16400419 DOI: 10.1590/s0004-282x2005000600017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 115 |
Lopes CV, Pereira-lima JC, Hartmann AA, Tonelotto E, Salgado K. O critério de positividade para a análise imunoistoquímica da p53 na confirmação da displasia do esôfago de Barrett faz diferença? Arq Gastroenterol 2005;42:233-7. [DOI: 10.1590/s0004-28032005000400008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 116 |
Mccluggage WG, Connolly LE, Mcgregor G, Hyland PL, Hall PA. A Strategy for Defining Biologically Relevant Levels of p53 Protein Expression in Clinical Samples with Reference to Endometrial Neoplasia: . International Journal of Gynecological Pathology 2005;24:307-12. [DOI: 10.1097/01.pgp.0000167113.86586.65] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 117 |
Steele RJ, Lane DP. P53 in cancer: a paradigm for modern management of cancer. Surgeon 2005;3:197-205. [PMID: 16076005 DOI: 10.1016/s1479-666x(05)80041-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 118 |
Sokołowska J, Cywińska A, Malicka E. p53 expression in canine lymphoma. J Vet Med A Physiol Pathol Clin Med 2005;52:172-5. [PMID: 15882401 DOI: 10.1111/j.1439-0442.2005.00707.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 119 |
Lee J, Kuo M, Cheng S, Chiang C, Jeng J, Chang H, Kuo Y, Lan W, Kok S. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2005;99:471-8. [DOI: 10.1016/j.tripleo.2004.10.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 120 |
Lopes CV, Pereira-Lima J, Hartmann AA. p53 immunohistochemical expression in Barrett's esophagus before and after endoscopic ablation by argon plasma coagulation. Scand J Gastroenterol 2005;40:259-63. [PMID: 15932166 DOI: 10.1080/00365520510011533] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 121 |
Pizem J, Cör A, Gale N. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology 2004;45:180-6. [PMID: 15279637 DOI: 10.1111/j.1365-2559.2004.01925.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 122 |
Mudhar HS, Parsons MA, Sisley K, Rundle P, Singh A, Rennie IG. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma. Histopathology 2004;45:1-12. [PMID: 15228438 DOI: 10.1111/j.1365-2559.2004.01874.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 123 |
Nenutil R, Smardova J, Pavlova S, Hanzelkova Z, Muller P, Fabian P, Hrstka R, Janotova P, Radina M, Lane D, Coates P, Vojtesek B. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry. J Pathol 2005;207:251-9. [DOI: 10.1002/path.1838] [Cited by in Crossref: 101] [Cited by in F6Publishing: 108] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 124 |
Matsumoto M, Furihata M, Kurabayashi A, Sasaguri S, Araki K, Hayashi H, Ohtsuki Y. Prognostic significance of serine 392 phosphorylation in overexpressed p53 protein in human esophageal squamous cell carcinoma. Oncology. 2004;67:143-150. [PMID: 15539919 DOI: 10.1159/000081001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 125 |
Pakos EE, Kyzas PA, Ioannidis JPA. Prognostic Significance of TP53 Tumor Suppressor Gene Expression and Mutations in Human Osteosarcoma. Clinical Cancer Research 2004;10:6208-6214. [DOI: 10.1158/1078-0432.ccr-04-0246] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 126 |
Takahashi S, Okada K, Nagasawa H, Shimada Y, Sakamoto H, Itoi E. Osteosarcoma occurring in osteogenesis imperfecta. Virchows Arch 2004;444:454-8. [PMID: 15214333 DOI: 10.1007/s00428-004-0985-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 127 |
Rocha FTR, Lourenço LG, Jucá MJ, Leal AT, Paz AMDCD. Expressão da proteína P53 no adenocarcinoma gástrico: correlação clínica, anatomopatológica e significância prognostica. Rev Col Bras Cir 2004;31:186-93. [DOI: 10.1590/s0100-69912004000300008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 128 |
Litofsky NS, Recht LD. The impact of p53 tumor suppressor gene on glioma biology. Neurosurg Focus 1997;3:e4. [PMID: 15104416 DOI: 10.3171/foc.1997.3.3.7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 129 |
Hassan A, Yerian LM, Kuan SF, Xiao SY, Hart J, Wang HL. Immunohistochemical evaluation of adenomatous polyposis coli, beta-catenin, c-Myc, cyclin D1, p53, and retinoblastoma protein expression in syndromic and sporadic fundic gland polyps. Hum Pathol. 2004;35:328-334. [PMID: 15017589 DOI: 10.1016/j.humpath.2003.10.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 130 |
Mitsumoto Y, Nakajima T, Marutani M, Kashiwazaki H, Moriguchi M, Kimura H, Okanoue T, Kagawa K, Tada M. Loss of p53 transcriptional activity in hepatocellular carcinoma evaluated by yeast-based functional assay: comparison with p53 immunohistochemistry. Human Pathology 2004;35:350-6. [DOI: 10.1016/j.humpath.2003.09.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 131 |
Wong NA, Rae F, Herriot MM, Mayer NJ, Brewster DH, Harrison DJ. SV40 Tag DNA sequences, present in a small proportion of human hepatocellular carcinomas, are associated with reduced survival. J Clin Pathol 2003;56:904-9. [PMID: 14645347 DOI: 10.1136/jcp.56.12.904] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 132 |
Zielinski C, Possinger K, Kiechle M. Mammakarzinom. Die Onkologie 2004. [DOI: 10.1007/978-3-662-06670-6_43] [Reference Citation Analysis]
|
| 133 |
Lu DW, El-Mofty SK, Wang HL. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Mod Pathol 2003;16:692-9. [PMID: 12861066 DOI: 10.1097/01.MP.0000077417.08371.CE] [Cited by in Crossref: 90] [Cited by in F6Publishing: 91] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 134 |
Sheen IS, Jeng KS, Wu JY. Is p53 gene mutation an indicatior of the biological behaviors of recurrence of hepatocellular carcinoma? World J Gastroenterol 2003; 9(6): 1202-1207 [PMID: 12800224 DOI: 10.3748/wjg.v9.i6.1202] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 135 |
Breuer RH, Snijders PJ, Sutedja TG, v d Linden H, Risse EK, Meijer CJ, Postmus PE, Smit EF. Suprabasal p53 immunostaining in premalignant endobronchial lesions in combination with histology is associated with bronchial cancer. Lung Cancer 2003;40:165-72. [PMID: 12711117 DOI: 10.1016/s0169-5002(03)00029-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 136 |
Hasegawa K, Suzuki M, Ishikawa K, Yasue A, Kato R, Nakamura A, Kuroki J, Udagawa Y. Establishment and characterization of a human uterine endometrial undifferentiated carcinoma cell line, TMG-L. Hum Cell 2003;16:31-8. [PMID: 12971623 DOI: 10.1111/j.1749-0774.2003.tb00126.x] [Reference Citation Analysis]
|
| 137 |
Kamel S, Zeiger S, Zalles C, Tawfik O, Kimler BF, Fabian CJ. p53 Immunopositivity and Gene Mutation in a Group of Women at High Risk for Breast Cancer. The Breast Journal 1998;4:396-404. [DOI: 10.1046/j.1524-4741.1998.450396.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 138 |
Kmet LM, Cook LS, Magliocco AM. A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors. Cancer 2003;97:389-404. [PMID: 12518363 DOI: 10.1002/cncr.11064] [Cited by in Crossref: 71] [Cited by in F6Publishing: 79] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 139 |
Nishioka M, Win SS, Myint B, Takagi M. Detection of p53, Bax, Rb, p16 and Human Papillomavirus DNA in Betel Quid Associated Oral Squamous Cell Carcinoma in Myanmar. Oral Med Pathol 2003;8:7-11. [DOI: 10.3353/omp.8.7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 140 |
Koch WM. Molecular Assessment of Surgical Margins. Head and Neck Cancer 2003. [DOI: 10.1016/b978-012239990-9/50036-9] [Reference Citation Analysis]
|
| 141 |
O'Neill lD. Comment on: F. Sandra et al. "The role of MDM2 in the proliferative activity of ameloblastoma", oral oncology 2002;38(2): 153-57. Oral Oncol 2002;38:806. [PMID: 12570062 DOI: 10.1016/s1368-8375(02)00023-4] [Reference Citation Analysis]
|
| 142 |
Motamed M, Powe D, Kendall C, Birchall JP, Banerjee AR. p53 Expression and keratinocyte hyperproliferation in middle ear cholesteatoma. Clin Otolaryngol Allied Sci 2002;27:505-8. [PMID: 12472520 DOI: 10.1046/j.1365-2273.2002.00622.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 143 |
Fokkema E, Groen HJ, Meijer C, Timens W, de Jong S, de Vries EG. The Role of Apoptosis-Related Genes in non—small-Cell Lung Cancer. Clinical Lung Cancer 2002;4:174-82. [DOI: 10.3816/clc.2002.n.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 144 |
Moskaluk CA. Standardization of clinical immunohistochemistry: why, how, and by whom? Am J Clin Pathol 2002;118:669-71. [PMID: 12428785 DOI: 10.1309/KM95-6LVL-UNLB-R3RH] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 145 |
Niu ZS, Li BK, Wang M. Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues. World J Gastroenterol 2002; 8(5): 822-826 [PMID: 12378623 DOI: 10.3748/wjg.v8.i5.822] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 146 |
Chen Y, Hsue S, Lin L. Immunohistochemical demonstration of p73 protein in the early stages of DMBA-induced squamous-cell carcinogenesis in hamster buccal pouch. Archives of Oral Biology 2002;47:695-9. [DOI: 10.1016/s0003-9969(02)00054-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 147 |
Hasegawa M, Ohoka I, Yamazaki K, Hanami K, Sugano I, Nagao T, Asoh A, Wada N, Nagao K, Ishida Y. Expression of p21/WAF-1, status of apoptosis and p53 mutation in esophageal squamous cell carcinoma with HPV infection. Pathol Int 2002;52:442-50. [PMID: 12167102 DOI: 10.1046/j.1440-1827.2002.01373.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 148 |
Kilicli-Camur N, Kilicaslan I, Gulluoglu MG, Esen T, Uysal V. Impact of p53 and Ki-67 in predicting recurrence and progression of superficial (pTa and pT1) urothelial cell carcinomas of urinary bladder. Pathol Int 2002;52:463-9. [PMID: 12167105 DOI: 10.1046/j.1440-1827.2002.01371.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 149 |
Liu MC, Gelmann EP. P53 gene mutations: case study of a clinical marker for solid tumors. Semin Oncol 2002;29:246-57. [PMID: 12063677 DOI: 10.1053/sonc.2002.32900] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 150 |
Jensen V, Brandt Sørensen F, Bentzen S, Ladekarl M, Steen Nielsen O, Keller J, Jensen O. Proliferative activity (MIB‐1 index) is an independent prognostic parameter in patients with high‐grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas. Histopathology 2002;32:536-46. [DOI: 10.1046/j.1365-2559.1998.00425.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 151 |
van Heek T, Rader AE, Offerhaus GJ, McCarthy DM, Goggins M, Hruban RH, Wilentz RE. K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis. Am J Clin Pathol 2002;117:755-65. [PMID: 12090425 DOI: 10.1309/5RQ0-JCQU-5XF2-51LQ] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 152 |
Sarela AI, Verbeke CS, Ramsdale J, Davies CL, Markham AF, Guillou PJ. Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br J Cancer 2002;86:886-92. [PMID: 11953819 DOI: 10.1038/sj.bjc.6600133] [Cited by in Crossref: 123] [Cited by in F6Publishing: 142] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 153 |
Guindi M, Riddell RH. Dysplasia in barrett's esophagus. New techniques and markers. Chest Surg Clin N Am 2002;12:59-68, viii-ix. [PMID: 11901933 DOI: 10.1016/s1052-3359(03)00088-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 154 |
Sandra F, Nakamura N, Kanematsu T, Hirata M, Ohishi M. The role of MDM2 in the proliferative activity of ameloblastoma. Oral Oncol 2002;38:153-7. [PMID: 11854062 DOI: 10.1016/s1368-8375(01)00036-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 155 |
Chang MS, Lee HS, Kim CW, Kim YI, Kim WH. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Pathol Res Pract 2001;197:395-400. [PMID: 11432666 DOI: 10.1078/0344-0338-00052] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 156 |
Wang HL. 16 Role of immunohistochemical expression of p53, Rb, and p16 proteins in anal squamous cell carcinoma. Molecular Pathology, Colorectal Carcinoma, and Prostate Carcinoma 2002. [DOI: 10.1016/s1874-5784(02)80032-0] [Reference Citation Analysis]
|
| 157 |
Sredni ST, de Camargo B, Lopes LF, Teixeira R, Simpson A. Immunohistochemical detection of p53 protein expression as a prognostic indicator in Wilms tumor. Med Pediatr Oncol 2001;37:455-8. [PMID: 11745874 DOI: 10.1002/mpo.1229] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 158 |
Martínez Ferreras A, Rodrigo Tapia J, González Meana M, Álvarez Álvarez I, Coto E, Suárez Nieto C. Asociación entre la integración del virus del papiloma humano y la pérdida de heterozigosidad del gen p53 en los carcinomas epidermoides de cabeza y cuello. Acta Otorrinolaringológica Española 2001;52:546-552. [DOI: 10.1016/s0001-6519(01)78249-0] [Reference Citation Analysis]
|
| 159 |
Gaumann A, Tews DS, Mayer E, Dahm M, Petrow PK, Otto M, Kirkpatrick CJ, Kriegsmann J. Expression of apoptosis-related proteins, p53, and DNA fragmentation in sarcomas of the pulmonary artery. Cancer 2001;92:1237-44. [PMID: 11571738 DOI: 10.1002/1097-0142(20010901)92:5<1237::aid-cncr1443>3.0.co;2-e] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 160 |
Okudela K, Nakamura N, Sano J, Ito T, Kitamura H. Thymic carcinosarcoma consisting of squamous cell carcinomatous and embryonal rhabdomyosarcomatous components. Report of a case and review of the literature. Pathol Res Pract 2001;197:205-10. [PMID: 11314786 DOI: 10.1078/0344-0338-00035] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 161 |
Pezeshki AM, Farjadian S, Talei A, Vasei M, Gharesi-Fard B, Doroudchi M, Ghaderi A. p53 gene alteration and protein expression in Iranian women with infiltrative ductal breast carcinoma. Cancer Lett 2001;169:69-75. [PMID: 11410327 DOI: 10.1016/s0304-3835(01)00557-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 162 |
Sadahira Y, Sugihara T, Yawata Y. Expression of p53 and Ki-67 antigen in bone marrow giant proerythroblasts associated with human parvovirus B19 infection. Int J Hematol 2001;74:147-52. [PMID: 11594514 DOI: 10.1007/BF02981997] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 163 |
Leichman CG. Predictive and prognostic markers in gastrointestinal cancers. Curr Opin Oncol 2001;13:291-9. [PMID: 11429488 DOI: 10.1097/00001622-200107000-00013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 164 |
Sironi G, Riccaboni P, Mertel L, Cammarata G, Brooks DE. p53 protein expression in conjunctival squamous cell carcinomas of domestic animals. Vet Ophthalmol 1999;2:227-31. [PMID: 11397270 DOI: 10.1046/j.1463-5224.1999.00086.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 165 |
Carlson JA, Amin S, Malfetano J, Tien AT, Selkin B, Hou J, Goncharuk V, Wilson VL, Rohwedder A, Ambros R, Ross JS. Concordant p53 and mdm-2 protein expression in vulvar squamous cell carcinoma and adjacent lichen sclerosus. Appl Immunohistochem Mol Morphol 2001;9:150-63. [PMID: 11396633 DOI: 10.1097/00129039-200106000-00008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 166 |
CORRESPONDENCE. The Breast 2001;10:263-265. [DOI: 10.1054/brst.2000.0194] [Reference Citation Analysis]
|
| 167 |
Motamed M, Banerjee AR, Bradley PJ, Powe D. MIB-1 and p53 expression in radiotherapy-resistant T1aN0M0 glottic squamous cell carcinoma. Clin Otolaryngol Allied Sci 2001;26:227-30. [PMID: 11437847 DOI: 10.1046/j.1365-2273.2001.00461.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 168 |
Buchwald C, Lindeberg H, Pedersen BL, Franzmann MB. Human papilloma virus and p53 expression in carcinomas associated with sinonasal papillomas: a Danish Epidemiological study 1980-1998. Laryngoscope 2001;111:1104-10. [PMID: 11404629 DOI: 10.1097/00005537-200106000-00032] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 169 |
Nasierowska-Guttmejer A, Trzeciak L, Nowacki MP, Ostrowski J. p53 protein accumulation and p53 gene mutation in colorectal cancer. Pathol Oncol Res 2000;6:275-9. [PMID: 11173660 DOI: 10.1007/BF03187331] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 170 |
Kraus JA, Wenghoefer M, Glesmann N, Mohr S, Beck M, Schmidt MC, Schröder R, Berweiler U, Roggendorf W, Diete S, Dietzmann K, Heuser K, Müller B, Fimmers R, von Deimling A, Schlegel U. TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme. J Neurooncol 2001;52:263-72. [PMID: 11519857 DOI: 10.1023/a:1010684203704] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 171 |
Mukherjee G, Freeman A, Moore R, Kumaraswamy, Devi KU, Morris LS, Coleman N, Dilworth S, Prabhakaran PS, Stanley MA. Biologic factors and response to radiotherapy in carcinoma of the cervix. Int J Gynecol Cancer 2001;11:187-93. [PMID: 11437923 DOI: 10.1046/j.1525-1438.2001.01014.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 172 |
Slaton JW, Benedict WF, Dinney CP. P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy. Urology 2001;57:852-9. [PMID: 11337281 DOI: 10.1016/s0090-4295(01)00968-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 173 |
Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Mod Pathol 2001;14:397-403. [PMID: 11353048 DOI: 10.1038/modpathol.3880324] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 174 |
Rakozy C, Grignon DJ, Li Y, Gheiler E, Gururajanna B, Pontes JE, Sakr W, Wood DP Jr, Sarkar FH. p53 gene alterations in prostate cancer after radiation failure and their association with clinical outcome: a molecular and immunohistochemical analysis. Pathol Res Pract 1999;195:129-35. [PMID: 10220791 DOI: 10.1016/S0344-0338(99)80024-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 175 |
Ceccarelli C, Santini D, Chieco P, Lanciotti C, Taffurelli M, Paladini G, Marrano D. Quantitative p21(waf-1)/p53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicators. Int J Cancer 2001;95:128-34. [PMID: 11241324 DOI: 10.1002/1097-0215(20010320)95:2<128::aid-ijc1022>3.0.co;2-d] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 176 |
Suliman M, Royds J, Cullen D, Timperley W, Powell T, Battersby R, Jones TH. Mdm2 and the p53 pathway in human pituitary adenomas. Clin Endocrinol (Oxf) 2001;54:317-25. [PMID: 11298083 DOI: 10.1046/j.1365-2265.2001.01195.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 177 |
Nambiar PR, Jackson ML, Ellis JA, Chelack BJ, Kidney BA, Haines DM. Immunohistochemical detection of tumor suppressor gene p53 protein in feline injection site-associated sarcomas. Vet Pathol 2001;38:236-8. [PMID: 11280384 DOI: 10.1354/vp.38-2-236] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 178 |
Chapusot C, Assem M, Martin L, Chalabreyssse L, Benhamiche AM, Lignier MA, Chauffert B, Teyssier JR, Faivre J, Piard F. [Expression of p21 WAF1/CIP1 protein in colorectal cancers: study of its relation to p53 mutation and Ki67 antigen expression]. Pathol Biol (Paris) 2001;49:115-23. [PMID: 11317955 DOI: 10.1016/s0369-8114(00)00015-8] [Reference Citation Analysis]
|
| 179 |
Lan Q, Feng Z, Tian D, He X, Rothman N, Tian L, Lu X, Terry MB, Mumford JL. p53 gene expression in relation to indoor exposure to unvented coal smoke in Xuan Wei, China. J Occup Environ Med 2001;43:226-30. [PMID: 11285870 DOI: 10.1097/00043764-200103000-00010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 180 |
Hill PA, Dwyer KM, Power DA. Chronic intestinal pseudo-obstruction in systemic lupus erythematosus due to intestinal smooth muscle myopathy. Lupus 2000;9:458-63. [PMID: 10981652 DOI: 10.1191/096120300678828505] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 181 |
Bánkfalvi A, Tory K, Kemper M, Breukelmann D, Cubick C, Poremba C, Füzesi L, Lellè RJ, Böcker W. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma. Pathol Res Pract 2000;196:489-501. [PMID: 10926327 DOI: 10.1016/S0344-0338(00)80051-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 182 |
McGarrity TJ, Peiffer LP, Granville DJ, Carthy CM, Levy JG, Khandelwal M, Hunt DW. Apoptosis associated with esophageal adenocarcinoma: influence of photodynamic therapy. Cancer Lett 2001;163:33-41. [PMID: 11163106 DOI: 10.1016/s0304-3835(00)00663-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 183 |
Ho ES, Lai CR, Hsieh YT, Chen JT, Lin AJ, Hung MH, Liu FS. p53 mutation is infrequent in clear cell carcinoma of the ovary. Gynecol Oncol 2001;80:189-93. [PMID: 11161858 DOI: 10.1006/gyno.2000.6025] [Cited by in Crossref: 66] [Cited by in F6Publishing: 73] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 184 |
Hakin-Smith V, Battersby RD, Maltby EL, Timperley WR, Royds JA. Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence. Neuropathol Appl Neurobiol 2001;27:40-9. [PMID: 11299001 DOI: 10.1046/j.0305-1846.2001.00300.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 185 |
Bradley G, Irish J, MacMillan C, Mancer K, Witterick I, Hartwick W, Gullane P, Kamel-Reid S, Benchimol S. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma. Oncogene 2001;20:654-8. [PMID: 11313998 DOI: 10.1038/sj.onc.1204131] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 186 |
Gross E, Kiechle M, Arnold N. Mutation analysis of p53 in ovarian tumors by DHPLC. J Biochem Biophys Methods 2001;47:73-81. [PMID: 11179763 DOI: 10.1016/s0165-022x(00)00153-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 187 |
Bernardini S, Billerey C, Martin M, Adessi GL, Wallerand H, Bittard H. The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma. J Urol 2001;165:42-6; discussion 46. [PMID: 11125360 DOI: 10.1097/00005392-200101000-00011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 188 |
Wijnhoven BPL, Dinjens WNM. Genetic Alterations. Barrett’s Esophagus 2001. [DOI: 10.1007/978-94-017-0829-6_14] [Reference Citation Analysis]
|
| 189 |
Tas F, Yavuz E, Aydiner A, Saip P, Disci R, Iplikci A, Topuz E. Angiogenesis and p53 protein expression in breast cancer: prognostic roles and interrelationships. Am J Clin Oncol 2000;23:546-53. [PMID: 11202793 DOI: 10.1097/00000421-200012000-00002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 190 |
Chang MS, Kim WH, Kim CW, Kim YI. Epstein-Barr virus in gastric carcinomas with lymphoid stroma. Histopathology 2000;37:309-15. [PMID: 11012737 DOI: 10.1046/j.1365-2559.2000.01014.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 191 |
de Alava E, Antonescu CR, Panizo A, Leung D, Meyers PA, Huvos AG, Pardo-mind�n FJ, Healey JH, Ladanyi M. Prognostic impact of P53 status in Ewing sarcoma. Cancer 2000;89:783-92. [DOI: 10.1002/1097-0142(20000815)89:4<783::aid-cncr10>3.0.co;2-q] [Cited by in Crossref: 110] [Cited by in F6Publishing: 117] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 192 |
Wong NA, Mayer NJ, MacKell S, Gilmour HM, Harrison DJ. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia. Histopathology 2000;37:108-14. [PMID: 10931232 DOI: 10.1046/j.1365-2559.2000.00934.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 100] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 193 |
Langendijk H, Thunnissen E, Arends JW, de Jong J, ten Velde G, Lamers R, Guinee D, Holden J, Wouters M. Cell proliferation and apoptosis in stage III inoperable non-small cell lung carcinoma treated by radiotherapy. Radiother Oncol 2000;56:197-207. [PMID: 10927139 DOI: 10.1016/s0167-8140(00)00218-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 194 |
Simonart T, Noel JC. Increased p53 staining in non-sun-exposed epidermis overlying Kaposi sarcoma. Am J Dermatopathol 2000;22:373-4. [PMID: 10949466 DOI: 10.1097/00000372-200008000-00016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 195 |
Rosen AC, Ausch C, Klein M, Graf AH, Metzenbauer M, Philipp K, Reiner A. p53 expression in fallopian tube carcinomas. Cancer Lett 2000;156:1-7. [PMID: 10840153 DOI: 10.1016/s0304-3835(00)00335-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 196 |
Lingen MW, Chang KW, McMurray SJ, Solt DB, Kies MS, Mittal BB, Haines GK, Pelzer HJ. Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck 2000;22:328-35. [PMID: 10862014 DOI: 10.1002/1097-0347(200007)22:4<328::aid-hed3>3.0.co;2-r] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 197 |
Chang K, Sarraj S, Lin S, Tsai P, Solt D. p53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 2000;21:1441-51. [DOI: 10.1093/carcin/21.5.441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 198 |
Chang K, Sarraj S, Lin S, Tsai P, Solt D. p53 expression, p53 and Ha- ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 2000;21:1441-51. [DOI: 10.1093/carcin/21.7.1441] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 199 |
Thompson-Hehir J, Davies MP, Green JA, Halliwell N, Joyce KA, Salisbury J, Sibson DR, Vergote I, Walker C. Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors. Diagn Mol Pathol 2000;9:110-9. [PMID: 10850547 DOI: 10.1097/00019606-200006000-00007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 200 |
Sittel C, Eckel HE, Damm M, von Pritzbuer E, Kvasnicka HM. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope 2000;110:1012-7. [PMID: 10852523 DOI: 10.1097/00005537-200006000-00024] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 201 |
Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci 2000;910:121-37; discussion 137-9. [PMID: 10911910 DOI: 10.1111/j.1749-6632.2000.tb06705.x] [Cited by in Crossref: 190] [Cited by in F6Publishing: 214] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 202 |
Salesiotis AN, Cullen KJ. Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging. Curr Opin Oncol 2000;12:229-39. [PMID: 10841195 DOI: 10.1097/00001622-200005000-00008] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 203 |
Geisler JP, Geisler HE, Miller GA, Wiemann MC, Zhou Z, Crabtree W. p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months. Gynecol Oncol 2000;77:278-82. [PMID: 10785478 DOI: 10.1006/gyno.2000.5780] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 204 |
Tammemagi MC, McLaughlin JR, Mullen JB, Bull SB, Johnston MR, Tsao MS, Casson AG. A study of smoking, p53 tumor suppressor gene alterations and non-small cell lung cancer. Ann Epidemiol 2000;10:176-85. [PMID: 10813511 DOI: 10.1016/s1047-2797(99)00048-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 205 |
Kaserer K, Schmaus J, Bethge U, Migschitz B, Fasching S, Walch A, Herbst F, Teleky B, Wrba F. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer. J Pathol 2000;190:450-6. [PMID: 10699994 DOI: 10.1002/(SICI)1096-9896(200003)190:4<450::AID-PATH545>3.0.CO;2-8] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 206 |
Shahnavaz SA, Regezi JA, Bradley G, Dubé ID, Jordan RC. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas. J Pathol 2000;190:417-22. [PMID: 10699989 DOI: 10.1002/(SICI)1096-9896(200003)190:4<417::AID-PATH544>3.0.CO;2-G] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 207 |
Wester K, Andersson AC, Ranefall P, Bengtsson E, Malmström PU, Busch C. Cultured human fibroblasts in agarose gel as a multi-functional control for immunohistochemistry. Standardization Of Ki67 (MIB1) assessment in routinely processed urinary bladder carcinoma tissue. J Pathol 2000;190:503-11. [PMID: 10700002 DOI: 10.1002/(SICI)1096-9896(200003)190:4<503::AID-PATH537>3.0.CO;2-E] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 208 |
Kaye PV, Radebold K, Isaacs S, Dent DM. Expression of p53 and p21waf1/cip1 in gastric carcinoma: lack of inter-relationship or correlation with prognosis. Eur J Surg Oncol 2000;26:39-43. [PMID: 10718178 DOI: 10.1053/ejso.1999.0738] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 209 |
Flammann HT, Kuhn H. p53 Autoantibodies and Cancer: Specificity, Diagnosis and Monitoring. Cancer and Autoimmunity 2000. [DOI: 10.1016/b978-044450331-2/50020-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 210 |
Meng L, Lin L, Zhang H, Nassiri M, Morales AR, Nadji M. Multiple mutations of the p53 gene in human mammary carcinoma. Mutat Res 1999;435:263-9. [PMID: 10606817 DOI: 10.1016/s0921-8777(99)00053-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 211 |
Hall PA, Going JJ. Predicting the future: a critical appraisal of cancer prognosis studies. Histopathology 1999;35:489-94. [PMID: 10583572 DOI: 10.1046/j.1365-2559.1999.00862.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 212 |
Krasna MJ, Mao YS, Sonett JR, Tamura G, Jones R, Suntharalingam M, Meltzer SJ. P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients. Ann Thorac Surg 1999;68:2021-4; discussion 2024-5. [PMID: 10616970 DOI: 10.1016/s0003-4975(99)01146-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 213 |
Craanen ME, Blok P, Offerhaus GJ, Meijer GA, Dekker W, Kuipers EJ, Meuwissen SG. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis. J Pathol 1999;189:481-6. [PMID: 10629547 DOI: 10.1002/(SICI)1096-9896(199912)189:4<481::AID-PATH482>3.0.CO;2-U] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 214 |
Sittel C, Ruiz S, Volling P, Kvasnicka HM, Jungehülsing M, Eckel HE. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity. Oral Oncol 1999;35:583-9. [PMID: 10705094 DOI: 10.1016/s1368-8375(99)00041-x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 215 |
Choufani G, Mahillon V, Decaestecker C, Lequeux T, Danguy A, Salmon I, Gabius HJ, Hassid S, Kiss R. Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and nonrecurrent cholesteatomas. Laryngoscope 1999;109:1825-31. [PMID: 10569415 DOI: 10.1097/00005537-199911000-00019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 216 |
Ishii N, Tada M, Hamou MF, Janzer RC, Meagher-Villemure K, Wiestler OD, Tribolet N, Van Meir EG. Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor. Oncogene 1999;18:5870-8. [PMID: 10557074 DOI: 10.1038/sj.onc.1203241] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 217 |
Jimenez RE, Warshaw AL, Z'graggen K, Hartwig W, Taylor DZ, Compton CC, Fernández-del Castillo C. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Ann Surg 1999;230:501-9; discussion 509-11. [PMID: 10522720 DOI: 10.1097/00000658-199910000-00006] [Cited by in Crossref: 142] [Cited by in F6Publishing: 152] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 218 |
Cury PM, Butcher DN, Corrin B, Nicholson AG. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis. J Pathol 1999;189:251-7. [PMID: 10547583 DOI: 10.1002/(SICI)1096-9896(199910)189:2<251::AID-PATH412>3.0.CO;2-F] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 219 |
Sato A, MacHinami R. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma. Pathol Int 1999;49:858-68. [PMID: 10571818 DOI: 10.1046/j.1440-1827.1999.00965.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 220 |
Taylor D, Koch WM, Zahurak M, Shah K, Sidransky D, Westra WH. Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations. Hum Pathol 1999;30:1221-5. [PMID: 10534171 DOI: 10.1016/s0046-8177(99)90041-2] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 221 |
Alò PL, Visca P, Mazzaferro S, Serpieri DE, Mangoni A, Botti C, Monaco S, Carboni M, Zaraca F, Trombetta G, Di Tondo U. Immunohistochemical study of fatty acid synthase, Ki67, proliferating cell nuclear antigen, and p53 expression in hyperplastic parathyroids. Ann Diagn Pathol 1999;3:287-93. [PMID: 10556475 DOI: 10.1016/s1092-9134(99)80024-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 222 |
Leahy DT, Mulcahy HE, O'Donoghue DP, Parfrey NA. bcl-2 protein expression is associated with better prognosis in colorectal cancer. Histopathology 1999;35:360-7. [PMID: 10564391 DOI: 10.1046/j.1365-2559.1999.00743.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 223 |
Häussler O, Epstein JI, Amin MB, Heitz PU, Hailemariam S. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer. Hum Pathol 1999;30:1077-86. [PMID: 10492043 DOI: 10.1016/s0046-8177(99)90226-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 224 |
Marrogi AJ, Khan MA, Vonderheid EC, Wood GS, McBurney E. p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: a study of 12 cases. J Cutan Pathol 1999;26:369-78. [PMID: 10551408 DOI: 10.1111/j.1600-0560.1999.tb01860.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 225 |
Wong CS, Tsao MS, Sharma V, Chapman WB, Pintilie M, Cummings BJ. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1999;45:309-14. [PMID: 10487550 DOI: 10.1016/s0360-3016(99)00188-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 226 |
Mayall F, Cursons R, Jacobson G, Chang B. Single-strand conformational polymorphism (SSCP)-detected p53 gene mutations are a less sensitive marker of malignancy in pleural fluids than p53 immunostaining. Cytopathology 1999;10:259-62. [PMID: 10458502 DOI: 10.1046/j.1365-2303.1999.00182.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 227 |
Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler KW, Vogelstein B. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 1999;104:263-9. [PMID: 10430607 DOI: 10.1172/JCI6863] [Cited by in Crossref: 779] [Cited by in F6Publishing: 861] [Article Influence: 32.5] [Reference Citation Analysis]
|
| 228 |
Feakins RM, Mulcahy HE, Nickols CD, Wells CA. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome. Histopathology 1999;35:162-9. [PMID: 10460662 DOI: 10.1046/j.1365-2559.1999.00682.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 229 |
Tworek H, Peng R, Fetzer S, Werness BA, Piver MS, Allen HJ, DiCioccio RA. Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors. Cancer Genet Cytogenet 1999;112:105-18. [PMID: 10686936 DOI: 10.1016/s0165-4608(98)00267-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 230 |
Whiteman DC, Green AC. Melanoma and sun exposure: where are we now? Int J Dermatol 1999;38:481-9. [PMID: 10440276 DOI: 10.1046/j.1365-4362.1999.00712.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 231 |
Lassaletta L, Alonso S, Ballestín C, Martínez-Tello FJ, Alvarez-Vicent JJ. Immunoreactivity in granular cell tumours of the larynx. Auris Nasus Larynx 1999;26:305-10. [PMID: 10419039 DOI: 10.1016/s0385-8146(98)00069-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 232 |
Sallinen SL, Sallinen PK, Kononen JT, Syrjäkoski KM, Nupponen NN, Rantala IS, Helén PT, Helin HJ, Haapasalo HK. Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis. J Pathol 1999;188:289-93. [PMID: 10419598 DOI: 10.1002/(SICI)1096-9896(199907)188:3<289::AID-PATH351>3.0.CO;2-X] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 233 |
Nehls O, Klump B, Holzmann K, Lammering G, Borchard F, Gruenagel H, Gaco V, Gregor M, Porschen R. Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma. Cancer 1999;85:2541-8. [DOI: 10.1002/(sici)1097-0142(19990615)85:12<2541::aid-cncr8>3.0.co;2-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 234 |
Voskuil DW, Kampman E, van Kraats AA, Balder HF, van Muijen GN, Goldbohm RA, van't Veer P. p53 over-expression and p53 mutations in colon carcinomas: relation to dietary risk factors. Int J Cancer 1999;81:675-81. [PMID: 10328215 DOI: 10.1002/(sici)1097-0215(19990531)81:5<675::aid-ijc1>3.0.co;2-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 235 |
Hammel P, Leroy-Viard K, Chaumette MT, Villaudy J, Falzone MC, Rouillard D, Hamelin R, Boissier B, Remvikos Y. Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer. Int J Cancer 1999;81:712-8. [PMID: 10328221 DOI: 10.1002/(sici)1097-0215(19990531)81:5<712::aid-ijc7>3.0.co;2-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 236 |
Kosma VM, Lang PS, Servomaa MK, Leszczynski D, Rytömaa TJ. Association of p53, K-ras and proliferating cell nuclear antigen with rat lung lesions following exposure to simulated nuclear fuel particles. Cancer Detect Prev 1999;23:194-203. [PMID: 10336998 DOI: 10.1046/j.1525-1500.1999.99026.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 237 |
Würl P, Meye A, Lautenschläger C, Schmidt H, Bache M, Kalthoff H, Schönfelder M, Rath FW, Taubert H. Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomas. Cancer Lett 1999;139:159-65. [PMID: 10395173 DOI: 10.1016/s0304-3835(99)00034-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 238 |
Hodak E, Hammel I, Feinmesser M, Zelinger A, Maron L, Sulkes J, David M. Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma. Am J Dermatopathol 1999;21:138-45. [PMID: 10218673 DOI: 10.1097/00000372-199904000-00005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 239 |
Davenport V, Morris JF, Motazed R, Chu AC. p53 induction in normal human skin in vitro following exposure to solar simulated UV and UV-B irradiation. J Photochem Photobiol B 1999;49:177-86. [PMID: 10392467 DOI: 10.1016/s1011-1344(99)00053-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 240 |
Haitel A, Wiener HG, Blaschitz U, Marberger M, Susani M. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers. Cancer 1999;85:1593-8. [PMID: 10193951 DOI: 10.1002/(sici)1097-0142(19990401)85:7<1593::aid-cncr22>3.0.co;2-k] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 241 |
van Oijen MG, van de Craats JG, Slootweg PJ. p53 overexpression in oral mucosa in relation to smoking. J Pathol 1999;187:469-74. [PMID: 10398108 DOI: 10.1002/(SICI)1096-9896(199903)187:4<469::AID-PATH262>3.0.CO;2-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 242 |
Akyol G, Dursun A, Poyraz A, Uluoglu O, Ataoglu O, Edalý N, Memis L. P53 and proliferating cell nuclear antigen (PCNA) expression in non-tumoral liver diseases. Pathol Int 1999;49:214-21. [PMID: 10338076 DOI: 10.1046/j.1440-1827.1999.00849.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 243 |
Chiang CP, Huang JS, Wang JT, Liu BY, Kuo YS, Hahn LJ, Kuo MY. Expression of p53 protein correlates with decreased survival in patients with areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1999;28:72-6. [PMID: 9950253 DOI: 10.1111/j.1600-0714.1999.tb01999.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 244 |
Tatemoto Y, Osaki T, Yoneda K, Yamamoto T, Ueta E, Kimura T. Expression of p53 and p21 proteins in oral squamous cell carcinoma: correlation with lymph node metastasis and response to chemoradiotherapy. Pathol Res Pract 1998;194:821-30. [PMID: 9894247 DOI: 10.1016/S0344-0338(98)80084-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 245 |
Blok P, Craanen ME, Dekker W, Offerhaus GJ, Tytgat GN. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis. J Pathol. 1998;186:36-40. [PMID: 9875138 DOI: 10.1002/(SICI)1096-9896(199809)186:1%3C36::AID-PATH150%3E3.0.CO;2-R] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 246 |
Lee YH, Ji JD, Kim A, Kim CH, Song GG. Expression of p53 protein in rheumatoid arthritis synovium. An immunohistochemical analysis. Korean J Intern Med 1999;14:59-65. [PMID: 10063315 DOI: 10.3904/kjim.1999.14.1.59] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 247 |
Schoelch ML, Le QT, Silverman S Jr, McMillan A, Dekker NP, Fu KK, Ziober BL, Regezi JA. Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Oral Oncol 1999;35:77-85. [PMID: 10211314 DOI: 10.1016/s1368-8375(98)00065-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 248 |
Luque EA, Tang LH, Bortecen KH, Kidd M, Miu K, Efstathiou JA, Modlin IM. Gastrin-regulated expression of p53 in transformed enterochromaffin-like cells in the African rodent mastomys. J Clin Gastroenterol 1998;27 Suppl 1:S116-24. [PMID: 9872508 DOI: 10.1097/00004836-199800001-00019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 249 |
Kelly JD, Williamson KE, Irvine AE, Hamilton PW, Weir HP, Anderson NH, Keane PF, Johnston SR. Apoptosis and its clinical significance for bladder cancer therapy. BJU Int 1999;83:1-10. [PMID: 10233445 DOI: 10.1046/j.1464-410x.1999.00871.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 250 |
Gadducci A, Ferdeghini M, Buttitta F, Cosio S, Fanucchi A, Annicchiarico C, Gagetti O, Bevilacqua G, Genazzani AR. Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer. Gynecol Oncol 1999;72:76-81. [PMID: 9889034 DOI: 10.1006/gyno.1998.5101] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 251 |
Campbell SJ, O’neill M, Hall PA. Function of the p53 Gene Family. Apoptosis and Cancer Chemotherapy 1999. [DOI: 10.1007/978-1-59259-720-8_4] [Reference Citation Analysis]
|
| 252 |
Reifenberger G, Kramm C, Bilzer T, Kiwit JCW. Gliale Neoplasien. Erkrankungen des Zentralnervensystems 1999. [DOI: 10.1007/978-3-662-07096-3_15] [Reference Citation Analysis]
|
| 253 |
Stewart RL, Royds JA, Burton JL, Heatley MK, Wells M. Direct sequencing of the p53 gene shows absence of mutations in endometrioid endometrial adenocarcinomas expressing p53 protein. Histopathology 1998;33:440-5. [PMID: 9839168 DOI: 10.1046/j.1365-2559.1998.00499.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 254 |
Keegan PE, Lunec J, Neal DE. p53 and p53-regulated genes in bladder cancer. Br J Urol 1998;82:710-20. [PMID: 9839588 DOI: 10.1046/j.1464-410x.1998.00822.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 255 |
Shrestha B, Ebihara Y, Osakabe Y, Kato H. Immunohistochemical, ultrastructural and molecular study of well differentiated adenocarcinomas of the lung predominantly composed of goblet cells. Lung Cancer 1998;22:103-17. [PMID: 10022218 DOI: 10.1016/s0169-5002(98)00052-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 256 |
Steele RJ, Thompson AM, Hall PA, Lane DP. The p53 tumour suppressor gene. Br J Surg 1998;85:1460-7. [PMID: 9823903 DOI: 10.1046/j.1365-2168.1998.00910.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 140] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 257 |
Dziadziuszko R, Jassem E, Jassem J. Clinical implications of molecular abnormalities in lung cancer. Cancer Treat Rev 1998;24:317-30. [PMID: 9861195 DOI: 10.1016/s0305-7372(98)90055-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 258 |
Allison RT, Best T. p53, PCNA and Ki-67 expression in oral squamous cell carcinomas: the vagaries of fixation and microwave enhancement of immunocytochemistry. J Oral Pathol Med 1998;27:434-40. [PMID: 9790097 DOI: 10.1111/j.1600-0714.1998.tb01981.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 259 |
De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ, Peeters PM, Slooff MJ, De Vries EG. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology 1998;28:971-9. [PMID: 9755233 DOI: 10.1002/hep.510280411] [Cited by in Crossref: 84] [Cited by in F6Publishing: 95] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 260 |
Jahnson S, Karlsson M. PREDICTIVE VALUE OF p53 AND pRb IMMUNOSTAINING IN LOCALLY ADVANCED BLADDER CANCER TREATED WITH CYSTECTOMY. Journal of Urology 1998;160:1291-6. [DOI: 10.1016/s0022-5347(01)62518-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 261 |
Kropveld A, Slootweg PJ, Blankenstein MA, Terhaard CH, Hordijk GJ. Ki-67 and p53 in T2 laryngeal cancer. Laryngoscope 1998;108:1548-52. [PMID: 9778299 DOI: 10.1097/00005537-199810000-00023] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 262 |
Berne B, Pontén J, Pontén F. Decreased p53 expression in chronically sun-exposed human skin after topical photoprotection. Photodermatol Photoimmunol Photomed 1998;14:148-53. [PMID: 9826884 DOI: 10.1111/j.1600-0781.1998.tb00033.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 263 |
Bouvier-Labit C, Chinot O, Ochi C, Gambarelli D, Dufour H, Figarella-Branger D. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas. Neuropathol Appl Neurobiol 1998;24:381-8. [PMID: 9821169 DOI: 10.1046/j.1365-2990.1998.00137.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 69] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 264 |
Whiteman DC, Parsons PG, Green AC. p53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer 1998;77:843-8. [PMID: 9714052 DOI: 10.1002/(sici)1097-0215(19980911)77:6<843::aid-ijc8>3.0.co;2-u] [Cited by in Crossref: 111] [Cited by in F6Publishing: 116] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 265 |
Chiba I, Muthumala M, Yamazaki Y, Uz Zaman A, Iizuka T, Amemiya A, Shibata T, Kashiwazaki H, Sugiura C, Fukuda H. Characteristics of mutations in the p53 gene of oral squamous-cell carcinomas associated with betel-quid chewing in Sri Lanka. Int J Cancer 1998;77:839-42. [PMID: 9714051 DOI: 10.1002/(sici)1097-0215(19980911)77:6<839::aid-ijc7>3.0.co;2-v] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 266 |
Zusman I. Gel fiberglass membranes for affinity chromatography columns and their application to cancer detection. J Chromatogr B Biomed Sci Appl 1998;715:297-306. [PMID: 9792517 DOI: 10.1016/s0378-4347(98)00022-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 267 |
Bubendorf L, Tapia C, Gasser TC, Casella R, Grunder B, Moch H, Mihatsch MJ, Sauter G. Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer. Hum Pathol 1998;29:949-54. [PMID: 9744310 DOI: 10.1016/s0046-8177(98)90199-x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 268 |
Blok P, Craanen ME, Dekker W, Offerhaus GJ, Tytgat GN. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis. J Pathol 1998;186:36-40. [PMID: 9875138 DOI: 10.1002/(SICI)1096-9896(199809)186:1<36::AID-PATH150>3.0.CO;2-R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 269 |
Jonas S, Springmeier G, Tauber R, Wiedenmann B, Lobeck H, Gessner R, Kreft B, Kling N, Moelling K, Neuhaus P. p53 mutagenesis in Klatskin tumors. Hum Pathol 1998;29:955-60. [PMID: 9744311 DOI: 10.1016/s0046-8177(98)90200-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 270 |
Carlson JA, Ambros R, Malfetano J, Ross J, Grabowski R, Lamb P, Figge H, Mihm MC Jr. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol 1998;29:932-48. [PMID: 9744309 DOI: 10.1016/s0046-8177(98)90198-8] [Cited by in Crossref: 193] [Cited by in F6Publishing: 196] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 271 |
Jessup JM, Loda M. Prognostic markers in rectal carcinoma. Semin Surg Oncol 1998;15:131-40. [PMID: 9730420 DOI: 10.1002/(sici)1098-2388(199809)15:2<131::aid-ssu11>3.0.co;2-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 272 |
DiCioccio RA, Werness BA, Peng R, Allen HJ, Piver MS. Correlation of TP53 mutations and p53 expression in ovarian tumors. Cancer Genet Cytogenet 1998;105:93-102. [PMID: 9723023 DOI: 10.1016/s0165-4608(98)00011-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 273 |
Bray SE, Schorl C, Hall PA. The challenge of p53: linking biochemistry, biology, and patient management. Stem Cells 1998;16:248-60. [PMID: 9708447 DOI: 10.1002/stem.160248] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 274 |
Hall PA. p53: The Challenge of Linking Basic Science and Patient Management. The Oncologist 1998;3:218-24. [DOI: 10.1634/theoncologist.3-4-218] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 275 |
Slebos RJ, Baas IO, Clement MJ, Offerhaus GJ, Askin FB, Hruban RH, Westra WH. p53 alterations in atypical alveolar hyperplasia of the human lung. Hum Pathol 1998;29:801-8. [PMID: 9712420 DOI: 10.1016/s0046-8177(98)90448-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 276 |
Ribeiro U, Finkelstein SD, Safatle-ribeiro AV, Landreneau RJ, Clarke MR, Bakker A, Swalsky PA, Gooding WE, Posner MC. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer 1998;83:7-18. [DOI: 10.1002/(sici)1097-0142(19980701)83:1<7::aid-cncr2>3.0.co;2-r] [Cited by in Crossref: 98] [Cited by in F6Publishing: 99] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 277 |
Gisbertz IA, Schouten HC, Bot FJ, Arends JW. Cell turnover parameters in small and large cell varieties of primary intestinal non-Hodgkin's lymphoma. Cancer 1998;83:158-65. [PMID: 9655306 DOI: 10.1002/(sici)1097-0142(19980701)83:1<158::aid-cncr21>3.0.co;2-v] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 278 |
Ter Harmsel, van Muyden, Smedts, Hermans, Kuijpers, Raikhlin, Petrov, Lebedev, Ramaekers, Trimbos. The significance of cell type and tumor growth markers in the prognosis of unscreened cervical cancer patients. Int J Gynecol Cancer 1998;8:336-44. [DOI: 10.1046/j.1525-1438.1998.09796.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 279 |
Freedman AN, Michalek AM, Weiss HA, Zhang ZF, Marshall JR, Mettlin CJ, Asirwatham JE, Petrelli NJ, Caporaso NE. Aspirin use and p53 expression in colorectal cancer. Cancer Detect Prev 1998;22:213-8. [PMID: 9618042 DOI: 10.1046/j.1525-1500.1998.0oa29.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 280 |
Watanabe T, Kelsey L, Ageitos A, Kuszynski C, Ino K, Heimann DG, Varney MT, Shepard HM, Vaillancourt MT, Maneval DC, Talmadge JE. Enhancement of adenovirus-mediated gene transfer to human bone marrow cells. Leuk Lymphoma 1998;29:439-51. [PMID: 9643558 DOI: 10.3109/10428199809050904] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 281 |
Sakai A, Oda K, Asaoku H, Shintaku S, Hoshino S, Okita H, Kimura A. Expressions of p53 and PCNA do not correlate with the international index or early response to chemotherapy in non-Hodgkin's lymphoma. Am J Hematol 1998;58:42-8. [PMID: 9590148 DOI: 10.1002/(sici)1096-8652(199805)58:1<42::aid-ajh8>3.0.co;2-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 282 |
Ohkoudo M, Sawa H, Hara M, Saruta K, Aiso T, Ohki R, Yamamoto H, Maemura E, Shiina Y, Fujii M, Saito I. Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas. J Neurooncol 1998;38:41-9. [PMID: 9540056 DOI: 10.1023/a:1005946001915] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 283 |
Save V, Nylander K, Hall PA. Why is p53 protein stabilized in neoplasia? Some answers but many more questions? J Pathol 1998;184:348-50. [PMID: 9664899 DOI: 10.1002/(SICI)1096-9896(199804)184:4<348::AID-PATH1227>3.0.CO;2-O] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 284 |
Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM, van der Waal I. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 1998;184:360-8. [PMID: 9664901 DOI: 10.1002/(SICI)1096-9896(199804)184:4<360::AID-PATH1263>3.0.CO;2-H] [Cited by in Crossref: 130] [Cited by in F6Publishing: 138] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 285 |
Williams C, Norberg T, Ahmadian A, Pontén F, Bergh J, Inganäs M, Lundeberg J, Uhlén M. Assessment of sequence-based p53 gene analysis in human breast cancer: messenger RNA in comparison with genomic DNA targets. Clinical Chemistry 1998;44:455-62. [DOI: 10.1093/clinchem/44.3.455] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 286 |
Akslen LA, Monstad SE, Larsen B, Straume O, Ogreid D. Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. Int J Cancer 1998;79:91-5. [PMID: 9495365 DOI: 10.1002/(sici)1097-0215(19980220)79:1<91::aid-ijc17>3.0.co;2-k] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 287 |
Rieger L, Weller M, Bornemann A, Schabet M, Dichgans J, Meyermann R. BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study. J Neurol Sci 1998;155:68-75. [PMID: 9562325 DOI: 10.1016/s0022-510x(97)00277-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 288 |
Li Y, Bhuiyan M, Vaitkevicius VK, Sarkar FH. Molecular analysis of the p53 gene in pancreatic adenocarcinoma. Diagn Mol Pathol 1998;7:4-9. [PMID: 9646028 DOI: 10.1097/00019606-199802000-00002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 289 |
Pomp J, Davelaar J, Blom J, van Krimpen C, Zwinderman A, Quint W, Immerzeel J. Radiotherapy for oesophagus carcinoma: the impact of p53 on treatment outcome. Radiother Oncol 1998;46:179-84. [PMID: 9510045 DOI: 10.1016/s0167-8140(97)00163-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 290 |
Karamitopoulou E, Perentes E, Tolnay M, Probst A. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 1998;29:140-5. [PMID: 9490273 DOI: 10.1016/s0046-8177(98)90224-6] [Cited by in Crossref: 90] [Cited by in F6Publishing: 99] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 291 |
McNicol AM, Richmond JA. Optimizing immunohistochemistry: antigen retrieval and signal amplification. Histopathology 1998;32:97-103. [PMID: 9543664 DOI: 10.1046/j.1365-2559.1998.00342.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 292 |
Seta T, Imazeki F, Yokosuka O, Saisho H, Suzuki T, Koide Y, Isono K. Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene. Dig Dis Sci 1998;43:279-89. [PMID: 9512119 DOI: 10.1023/a:1018889818855] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 293 |
Narayana A, Vaughan AT, Gunaratne S, Kathuria S, Walter SA, Reddy SP. Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer 1998;82:286-91. [PMID: 9445184 DOI: 10.1002/(sici)1097-0142(19980115)82:2<286::aid-cncr7>3.0.co;2-p] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 294 |
Benini E, Costa A, Abolafio G, Silvestrini R. p53 expression in human carcinomas: could flow cytometry be an alternative to immunohistochemistry? J Histochem Cytochem 1998;46:41-8. [PMID: 9405493 DOI: 10.1177/002215549804600106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 295 |
Wilentz RE, Slebos RJC, Hruban RH. Screening for Pancreatic Cancer Using Techniques to Detect Altered Gene Products. Pancreatic Cancer 1998. [DOI: 10.1007/978-1-4612-1810-4_6] [Reference Citation Analysis]
|
| 296 |
Weintraub M, Bhatia KG, Chandra RS, Magrath IT, Ladisch S. p53 expression in Langerhans cell histiocytosis. J Pediatr Hematol Oncol 1998;20:12-7. [PMID: 9482407 DOI: 10.1097/00043426-199801000-00002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 297 |
Daidone MG, Benini E, Rao S, Pilotti S, Silvestrini R. Fixation Time and Microwave Oven Irradiation Affect Immunocytochemical p53 Detection in Formalin-Fixed Paraffin Sections: . Applied Immunohistochemistry 1998;6:140-4. [DOI: 10.1097/00022744-199809000-00006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 298 |
Hayes AJ, Oates AJ. Flow cytometric analysis of p53 oncoprotein expression in cutaneous melanoma. Br J Surg 1997;84:1751-2. [PMID: 9448640 DOI: 10.1002/bjs.1800841236] [Reference Citation Analysis]
|
| 299 |
Pellín A, Boix-Ferrero J, Carpio D, López-Terrada D, Carda C, Navarro S, Peydró-Olaya A, Triche TJ, Llombart-Bosch A. Molecular alterations of the RB1, TP53, and MDM2 genes in primary and xenografted human osteosarcomas. Diagn Mol Pathol 1997;6:333-41. [PMID: 9559293 DOI: 10.1097/00019606-199712000-00005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 300 |
Tseng S, Yu J, Yue C, Chang S, Chang T, Wu C, Shen C. Allelic loss atBRCA1, BRCA2, and adjacent loci in relation toTP53 abnormality in breast cancer. Genes Chromosom Cancer 1997;20:377-82. [DOI: 10.1002/(sici)1098-2264(199712)20:4<377::aid-gcc9>3.0.co;2-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 301 |
Würl P, Taubert H, Meye A, Berger D, Lautenschläger C, Holzhausen HJ, Schmidt H, Kalthoff H, Rath FW, Dralle H. Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies. J Cancer Res Clin Oncol 1997;123:502-8. [PMID: 9341900 DOI: 10.1007/BF01192205] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 302 |
Würl P, Meye A, Berger D, Bache M, Lautenschläger C, Schmidt H, Kalthoff H, Rath FW, Taubert H. Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas. Diagn Mol Pathol 1997;6:249-54. [PMID: 9458382 DOI: 10.1097/00019606-199710000-00001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 303 |
Langlois NE, Lamb J, Eremin O, Heys SD. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. J Pathol 1997;182:392-7. [PMID: 9306959 DOI: 10.1002/(SICI)1096-9896(199708)182:4<392::AID-PATH874>3.0.CO;2-G] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 304 |
Oka M, Kounoura K, Narasaki F, Sakamoto A, Fukuda M, Matsuo I, Ikeda K, Tsurutani J, Ikuno N, Omagari K, Mizuta Y, Soda H, Gudas JM, Kohno S. P-glycoprotein is positively correlated with p53 protein accumulation in human colorectal cancers. Jpn J Cancer Res 1997;88:738-42. [PMID: 9330605 DOI: 10.1111/j.1349-7006.1997.tb00445.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 305 |
Murphy M, McManus DT, Toner PG, Russell SE. TP53 mutation in ovarian carcinoma. Eur J Cancer 1997;33:1281-3. [PMID: 9301456 DOI: 10.1016/s0959-8049(97)00108-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 306 |
Kitamura H, Nakatani Y, Kameda Y. Expression of p53 and CEA in Atypical Adenomatous Hyperplasia of the Lung. The American Journal of Surgical Pathology 1997;21:868. [DOI: 10.1097/00000478-199707000-00019] [Reference Citation Analysis]
|
| 307 |
Hughes SE. Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem 1997;45:1005-19. [PMID: 9212826 DOI: 10.1177/002215549704500710] [Cited by in Crossref: 189] [Cited by in F6Publishing: 194] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 308 |
Cooper K, Haffajee Z. bcl-2 and p53 protein expression in follicular lymphoma. J Pathol 1997;182:307-10. [PMID: 9349233 DOI: 10.1002/(SICI)1096-9896(199707)182:3<307::AID-PATH873>3.0.CO;2-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 309 |
Ogden GR, Chisholm DM, Morris AM, Stevenson JH. Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease. J Pathol 1997;182:180-4. [PMID: 9274528 DOI: 10.1002/(SICI)1096-9896(199706)182:2<180::AID-PATH847>3.0.CO;2-L] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 310 |
Kashiwagi H, Spigelman AD, Talbot IC, Debinski HS, Mckie AB, Lemoine NR, Phillips RKS. p53 and K-ras status in duodenal adenomas in familial adenomatous polyposis. Br J Surg 1997;84:826-9. [DOI: 10.1002/bjs.1800840627] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 311 |
Gibson GE, O'Grady A, Kay EW, Leader M, Murphy GM. p53 tumor suppressor gene protein expression in premalignant and malignant skin lesions of kidney transplant recipients. J Am Acad Dermatol 1997;36:924-31. [PMID: 9204056 DOI: 10.1016/s0190-9622(97)80274-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 312 |
Kashiwagi H, Spigelman AD, Talbot IC, Debinski HS, Mckie AB, Lemoine NR, Phillips RKS. p53 and K-ras status in duodenal adenomas in familial adenomatous polyposis. Br J Surg 1997;84:826-829. [DOI: 10.1046/j.1365-2168.1997.02677.x] [Reference Citation Analysis]
|
| 313 |
Zhu QR, White FH, Tipoe GL. p53 oncoprotein accumulation in adenoid cystic carcinoma of parotid and palatine salivary glands. Pathology 1997;29:154-8. [PMID: 9213334 DOI: 10.1080/00313029700169784] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 314 |
Lonardo F, Ueda T, Huvos AG, Healey J, Ladanyi M. p53 and MDM2 alterations in osteosarcomas: Correlation with clinicopathologic features and proliferative rate. Cancer 1997;79:1541-7. [DOI: 10.1002/(sici)1097-0142(19970415)79:8<1541::aid-cncr15>3.0.co;2-y] [Cited by in Crossref: 98] [Cited by in F6Publishing: 103] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 315 |
Kowalski LD, Kanbour AI, Price FV, Finkelstein SD, Christopherson WA, Seski JC, Naus GJ, Burnham JA, Kanbour-shakir A, Edwards RP. A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma. Cancer 1997;79:1587-94. [DOI: 10.1002/(sici)1097-0142(19970415)79:8<1587::aid-cncr22>3.0.co;2-t] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 316 |
Piffkó J, Bánkfalvi A. [Immunohistochemical expression of p53 protein in squamous epithelial carcinomas and normal and dysplastic epithelium of the mouth cavity]. Mund Kiefer Gesichtschir 1997;1:104-7. [PMID: 9410611 DOI: 10.1007/BF03043523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 317 |
Schmid M, Janssen K, Dockhorn-Dworniczak B, Metze D, Zelger BW, Luger TA, Schmid KW. p53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin. An immunohistochemical and SSCP analysis. Virchows Arch 1997;430:233-7. [PMID: 9099981 DOI: 10.1007/BF01324807] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 318 |
Munck-Wikland E, Kuylenstierna R, Lindholm J, Auer G. p53 immunostaining and image cytometry DNA analysis in precancerous and cancerous squamous epithelial lesions of the larynx. Head Neck 1997;19:107-15. [PMID: 9059867 DOI: 10.1002/(sici)1097-0347(199703)19:2<107::aid-hed4>3.0.co;2-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 319 |
Shivapurkar N, Nikula KJ, Tanaka T, Tang ZC, Alabaster O. Absence of p53 gene mutations in rat colon carcinomas induced through the synergistic interaction between methylazoxymethanol and X-irradiation. Cancer Lett 1997;113:9-16. [PMID: 9065795 DOI: 10.1016/s0304-3835(96)04551-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 320 |
Arai M, Shimizu S, Imai Y, Nakatsuru Y, Oda H, Oohara T, Ishikawa T. Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine. Int J Cancer 1997;70:390-5. [PMID: 9033644 DOI: 10.1002/(sici)1097-0215(19970207)70:4<390::aid-ijc3>3.0.co;2-r] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 321 |
Hardwick RH, Barham CP, Ozua P, Newcomb PV, Savage P, Powell R, Rahamin J, Alderson D. Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis. Eur J Surg Oncol 1997;23:30-5. [PMID: 9066744 DOI: 10.1016/s0748-7983(97)80139-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 322 |
Hoogsteden HC, Langerak AW, van der Kwast TH, Versnel MA, van Gelder T. Malignant pleural mesothelioma. Crit Rev Oncol Hematol 1997;25:97-126. [PMID: 9134313 DOI: 10.1016/s1040-8428(96)00231-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 323 |
Pereira H, Silva S, Julião R, Garcia P, Perpétua F. Prognostic markers for colorectal cancer: expression of P53 and BCL2. World J Surg 1997;21:210-3. [PMID: 8995081 DOI: 10.1007/s002689900218] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 324 |
Kench JG, Eckstein RP, Smith RC. Intraductal papillary-mucinous neoplasm of the pancreas: a report of five cases with immunohistochemical findings. Pathology 1997;29:7-11. [PMID: 9094170 DOI: 10.1080/00313029700169454] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 325 |
Schneider-Stock R, Radig K, Oda Y, Mellin W, Rys J, Niezabitowski A, Roessner A. p53 gene mutations in soft-tissue sarcomas--correlations with p53 immunohistochemistry and DNA ploidy. J Cancer Res Clin Oncol 1997;123:211-8. [PMID: 9177493 DOI: 10.1007/BF01240317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 326 |
Husgafvel-pursiainen K, Kannio A, Oksa P, Suitiala T, Koskinen H, Partanen R, Hemminki K, Smith S, Rosenstock-leibu R, Brandt-rauf PW. Mutations, tissue accumulations, and serum levels of p53 in patients with occupational cancers from asbestos and silica exposure. Environ Mol Mutagen 1997;30:224-30. [DOI: 10.1002/(sici)1098-2280(1997)30:2<224::aid-em15>3.0.co;2-f] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 327 |
Moch H, Sauter G, Gasser TC, Buchholz N, Bubendorf L, Richter J, Jiang F, Dellas A, Mihatsch MJ. p53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma. Urol Res 1997;25 Suppl 1:S25-30. [PMID: 9079753 DOI: 10.1007/BF00942044] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 328 |
Luzar B, Gale N, Kambic V, Poljak M, Zidar N, Vodovnik A. Human papillomavirus infection and expression of p53 and c-erbB-2 protein in laryngeal papillomas. Acta Otolaryngol Suppl 1997;527:120-4. [PMID: 9197499 DOI: 10.3109/00016489709124052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 329 |
Visscher DW, Sarkar FH, Crissman JD. Molecular genetic analysis in the pathologic evaluation of solid tumors: Theory and practice. J Clin Lab Anal 1997;11:10-6. [DOI: 10.1002/(sici)1098-2825(1997)11:1<10::aid-jcla3>3.0.co;2-o] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 330 |
Hollstein M, Soussi T, Thomas G, von Brevern MC, Bartsch. P53 gene alterations in human tumors: perspectives for cancer control. Recent Results Cancer Res 1997;143:369-89. [PMID: 8912433 DOI: 10.1007/978-3-642-60393-8_26] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 331 |
Pápai Z, Féja CN, Hanna EN, Sztán M, Oláh E, Szendrôi M. P53 Overexpression as an Indicator of Overall Survival and Response to Treatment in Osteosarcomas. Pathol Oncol Res 1997;3:15-9. [PMID: 11173619 DOI: 10.1007/BF02893346] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 332 |
Hasegawa M, Yamakawa M, Mitsuhashi N, Ohno T, Imai R, Sato R, Shiojima K, Niibe H. Relationship between apoptosis and p53 protein expression in squamous cell carcinoma of the esophagus. ACRT 1997;5:91-94. [DOI: 10.4993/acrt1992.5.91] [Reference Citation Analysis]
|
| 333 |
Wilson RH, Whiteside MC, Russell SE. Molecular genetics of colorectal cancer (part 1). Clin Oncol (R Coll Radiol) 1997;9:14-9. [PMID: 9039808 DOI: 10.1016/s0936-6555(97)80052-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 334 |
Nadji M, Meng L, Lin L, Nassiri M, Morales AR. Detection of p53 gene abnormality by sequence analysis of archival paraffin tissue. A comparison with fresh-frozen specimens. Diagn Mol Pathol 1996;5:279-83. [PMID: 8955620 DOI: 10.1097/00019606-199612000-00009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 335 |
Leahy DT, Salman R, Mulcahy H, Sheahan K, O'Donoghue DP, Parfrey NA. Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis. J Pathol 1996;180:364-70. [PMID: 9014855 DOI: 10.1002/(SICI)1096-9896(199612)180:4<364::AID-PATH683>3.0.CO;2-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 336 |
Moskaluk CA, Heitmiller R, Zahurak M, Schwab D, Sidransky D, Hamilton SR. p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction. Hum Pathol 1996;27:1211-20. [PMID: 8912833 DOI: 10.1016/s0046-8177(96)90317-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 337 |
Cagle PT, Fraire AE, Greenberg SD, Cox A, Brown RW. Potential utility of p53 immunopositivity in differentiation of adenocarcinomas from reactive epithelial atypias of the lung. Hum Pathol 1996;27:1198-203. [PMID: 8912831 DOI: 10.1016/s0046-8177(96)90315-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 338 |
Dowell SP, McGoogan E, Picksley SM, el-Deiry WS, Vogelstein B, Hall PA. Expression of p21waf1/Cip1, MDM2 and p53 in vivo: analysis of cytological preparations. Cytopathology 1996;7:340-51. [PMID: 8911758 DOI: 10.1111/j.1365-2303.1996.tb00313.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 339 |
Soong R, Robbins PD, Dix BR, Grieu F, Lim B, Knowles S, Williams KE, Turbett GR, House AK, Iacopetta BJ. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Hum Pathol 1996;27:1050-5. [PMID: 8892589 DOI: 10.1016/s0046-8177(96)90282-8] [Cited by in Crossref: 117] [Cited by in F6Publishing: 122] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 340 |
Ogden GR. Recurrence of malignant tumours in the head and neck. BMJ 1996;313:700-1. [PMID: 8819426 DOI: 10.1136/bmj.313.7059.700] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 341 |
Yaziji H, Massarani-Wafai R, Gujrati M, Kuhns JG, Martin AW, Parker JC Jr. Role of p53 immunohistochemistry in differentiating reactive gliosis from malignant astrocytic lesions. Am J Surg Pathol 1996;20:1086-90. [PMID: 8764745 DOI: 10.1097/00000478-199609000-00006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 342 |
Visscher DW, Sarkar FH, Shimoyama RK, Crissman JD. Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma. Diagn Mol Pathol 1996;5:187-93. [PMID: 8866232 DOI: 10.1097/00019606-199609000-00007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 343 |
Bristow RG, Benchimol S, Hill RP. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol 1996;40:197-223. [PMID: 8940748 DOI: 10.1016/0167-8140(96)01806-3] [Cited by in Crossref: 125] [Cited by in F6Publishing: 139] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 344 |
Kropveld A, Slootweg PJ, van Mansfeld AD, Blankenstein MA, Hordijk GJ. Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresis. Cancer 1996;78:991-7. [PMID: 8780536 DOI: 10.1002/(SICI)1097-0142(19960901)78:5<991::AID-CNCR8>3.0.CO;2-F] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 345 |
Ilyas M, Tomlinson IP, Novelli MR, Hanby A, Bodmer WF, Talbot IC. Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability. J Pathol 1996;179:370-5. [PMID: 8869282 DOI: 10.1002/(SICI)1096-9896(199608)179:4<370::AID-PATH627>3.0.CO;2-N] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 346 |
Mansoor A, McKee PH, Simpson JA, McGuire B, Hobbs C. Prognostic significance of Ki-67 and p53 immunoreactivity in cutaneous squamous cell carcinomas. Am J Dermatopathol 1996;18:351-7. [PMID: 8879297 DOI: 10.1097/00000372-199608000-00004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 347 |
Stattin P, Damber JE, Modig H, Bergh A. Pretreatment p53 immunoreactivity does not infer radioresistance in prostate cancer patients. Int J Radiat Oncol Biol Phys 1996;35:885-9. [PMID: 8751397 DOI: 10.1016/0360-3016(96)00134-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 348 |
Pich A, Margaria E, Chiusa L, Ponti R, Geuna M. DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma. Hum Pathol 1996;27:676-82. [PMID: 8698311 DOI: 10.1016/s0046-8177(96)90397-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 349 |
Hanski C, Tiecke F, Hummel M, Hanski ML, Ogorek D, Rolfs A, Schmitt-Gräff A, Stein H, Riecken EO. Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas. Cancer Lett 1996;103:163-70. [PMID: 8635153 DOI: 10.1016/0304-3835(96)04208-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 350 |
Wertz IE, Deitch AD, Gumerlock PH, Gandour-Edwards R, Chi SG, de Vere White RW. Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissues. Hum Pathol 1996;27:573-80. [PMID: 8666367 DOI: 10.1016/s0046-8177(96)90164-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 351 |
Papadaki H, Finkelstein SD, Kounelis S, Bakker A, Swalsky PA, Kapadia SB. The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma. Hum Pathol 1996;27:567-72. [PMID: 8666366 DOI: 10.1016/s0046-8177(96)90163-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 352 |
McManus DT, Murphy M, Arthur K, Hamilton PW, Russell SE, Toner PG. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma. J Pathol 1996;179:177-82. [PMID: 8758210 DOI: 10.1002/(SICI)1096-9896(199606)179:2<177::AID-PATH561>3.0.CO;2-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 353 |
Lee CS. Lack of p53 immunoreactivity in pancreatic endocrine tumors. Pathology 1996;28:139-41. [PMID: 8743819 DOI: 10.1080/00313029600169753] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 354 |
Li TJ, Browne RM, Prime SS, Paterson IC, Matthews JB. p53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med 1996;25:249-55. [PMID: 8835823 DOI: 10.1111/j.1600-0714.1996.tb01380.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 355 |
Kitamura H, Kameda Y, Nakamura N, Inayama Y, Nakatani Y, Shibagaki T, Ito T, Hayashi H, Kimura H, Kanisawa M. Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol 1996;20:553-62. [PMID: 8619420 DOI: 10.1097/00000478-199605000-00002] [Cited by in Crossref: 94] [Cited by in F6Publishing: 98] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 356 |
Raybaud-Diogène H, Tétu B, Morency R, Fortin A, Monteil RA. p53 overexpression in head and neck squamous cell carcinoma: review of the literature. Eur J Cancer B Oral Oncol 1996;32B:143-9. [PMID: 8762869 DOI: 10.1016/0964-1955(95)00095-x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 357 |
Seshadri R, Leong AS, McCaul K, Firgaira FA, Setlur V, Horsfall DJ. Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis. Int J Cancer 1996;69:135-41. [PMID: 8608982 DOI: 10.1002/(SICI)1097-0215(19960422)69:2<135::AID-IJC12>3.0.CO;2-8] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 358 |
Washington K, Gottfried MR. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Liver 1996;16:99-104. [PMID: 8740842 DOI: 10.1111/j.1600-0676.1996.tb00712.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 359 |
Kusama K, Okutsu S, Takeda A, Himiya T, Kojima A, Kidokoro Y, Chu L, Iwanari S, Kudo I, Moro I. p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma. J Pathol 1996;178:415-21. [PMID: 8691320 DOI: 10.1002/(SICI)1096-9896(199604)178:4<415::AID-PATH548>3.0.CO;2-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 360 |
Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 1996;27:360-5. [PMID: 8617479 DOI: 10.1016/s0046-8177(96)90109-4] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 361 |
Müller W, Borchard F. Prognostic influence of p53 expression in gastric cancer. J Pathol 1996;178:255-8. [PMID: 8778328 DOI: 10.1002/(SICI)1096-9896(199603)178:3<255::AID-PATH468>3.0.CO;2-V] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 362 |
Matsuta M, Kimura S, Kosegawa G, Kon S, Matsuta M. Immunohistochemical detection of Ki-67 in epithelial skin tumors in formalin-fixed paraffin-embedded tissue sections using a new monoclonal antibody (MIB-1). J Dermatol 1996;23:147-52. [PMID: 8935623 DOI: 10.1111/j.1346-8138.1996.tb03989.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 363 |
Sagartz JE, Bodley WL, Gamblin RM, Couto CG, Tierney LA, Capen CC. p53 tumor suppressor protein overexpression in osteogenic tumors of dogs. Vet Pathol 1996;33:213-21. [PMID: 8801715 DOI: 10.1177/030098589603300211] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 364 |
Baas IO, van den Berg FM, Mulder JW, Clement MJ, Slebos RJ, Hamilton SR, Offerhaus GJ. Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms. J Pathol 1996;178:264-7. [PMID: 8778330 DOI: 10.1002/(SICI)1096-9896(199603)178:3<264::AID-PATH485>3.0.CO;2-#] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 365 |
Dowell SP, Ogden GR. The use of antigen retrieval for immunohistochemical detection of p53 over-expression in malignant and benign oral mucosa: a cautionary note. J Oral Pathol Med 1996;25:60-4. [PMID: 8667257 DOI: 10.1111/j.1600-0714.1996.tb00193.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 366 |
Awwad S, Jaros E, Somes J, Lunec J. P53 overexpression in head and neck carcinoma and radiotherapy results. Int J Radiat Oncol Biol Phys 1996;34:323-32. [PMID: 8567333 DOI: 10.1016/0360-3016(95)02108-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 367 |
Berg RJ, van Kranen HJ, Rebel HG, de Vries A, van Vloten WA, Van Kreijl CF, van der Leun JC, de Gruijl FR. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci U S A 1996;93:274-8. [PMID: 8552621 DOI: 10.1073/pnas.93.1.274] [Cited by in Crossref: 158] [Cited by in F6Publishing: 157] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 368 |
Poljak M, Cerar A, Orlowska J. p53 protein expression in esophageal squamous cell papillomas: a study of 36 lesions. Scand J Gastroenterol 1996;31:10-3. [PMID: 8927934 DOI: 10.3109/00365529609031620] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 369 |
van der Kooy K, Rookus MA, Peterse HL, van Leeuwen FE. p53 and Neu (c-erbB-2) Overexpression in Relation to Risk Factors for Breast Cancer. Hormonal Carcinogenesis II 1996. [DOI: 10.1007/978-1-4612-2332-0_48] [Reference Citation Analysis]
|
| 370 |
Slootweg PJ. Suppressor protein p53 and its occurrence in oral tumours. Curr Top Pathol 1996;90:179-200. [PMID: 8791752 DOI: 10.1007/978-3-642-80169-3_6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 371 |
Dalquen P, Sauter G, Torhorst J, Schultheiss E, Jordan P, Lehmann S, Solèr M, Stulz P, Mihatsch MJ, Gudat F. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma. J Pathol 1996;178:53-8. [PMID: 8778317 DOI: 10.1002/(SICI)1096-9896(199601)178:1<53::AID-PATH415>3.0.CO;2-T] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 372 |
Lombardi T, Odell EW, Morgan PR. p53 immunohistochemistry of odontogenic keratocysts in relation to recurrence, basal-cell budding and basal-cell naevus syndrome. Arch Oral Biol 1995;40:1081-4. [PMID: 8850645 DOI: 10.1016/0003-9969(95)00092-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 373 |
Karamitopoulou E, Perentes E, Diamantis I, Vogt U, Wegmann W. p53 protein expression in colorectal adenomas: an immunohistochemical study using an antigen retrieval system. Histopathology 1995;27:517-23. [PMID: 8838331 DOI: 10.1111/j.1365-2559.1995.tb00322.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 374 |
Lam KY, Chan AC, Chan KW, Leung ML, Srivastava G. Expression of p53 and its relationship with human papillomavirus in penile carcinomas. Eur J Surg Oncol 1995;21:613-6. [PMID: 8631406 DOI: 10.1016/s0748-7983(95)95262-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 375 |
Ilyas M, Talbot IC. p53 expression in ulcerative colitis: a longitudinal study. Gut 1995;37:802-4. [PMID: 8537051 DOI: 10.1136/gut.37.6.802] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 376 |
Dowell SP, Hall PA. The p53 tumour suppressor gene and tumour prognosis: is there a relationship? J Pathol 1995;177:221-4. [PMID: 8551382 DOI: 10.1002/path.1711770302] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 377 |
Lee CS, Pirdas A, Lee MW. p53 in cutaneous melanoma: immunoreactivity and correlation with prognosis. Australas J Dermatol 1995;36:192-5. [PMID: 8593106 DOI: 10.1111/j.1440-0960.1995.tb00971.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 378 |
Slootweg PJ. p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. J Oral Pathol Med 1995;24:393-7. [PMID: 8537911 DOI: 10.1111/j.1600-0714.1995.tb01207.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 126] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 379 |
Hald J, Rasmussen N, Claesson MH. Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck. Cancer Immunol Immunother 1995;41:243-50. [PMID: 7489567 DOI: 10.1007/BF01516999] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 380 |
Gabbert HE, Müller W, Schneiders A, Meier S, Hommel G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 1995;76:720-6. [DOI: 10.1002/1097-0142(19950901)76:5<720::aid-cncr2820760503>3.0.co;2-e] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 381 |
Nakopoulou L, Constantinides C, Papandropoulos J, Theodoropoulos G, Tzonou A, Giannopoulos A, Zervas A, Dimopoulos C. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy. Urology 1995;46:334-40. [PMID: 7660508 DOI: 10.1016/S0090-4295(99)80216-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 382 |
Gabbert HE, Müller W, Schneiders A, Meier S, Hommel G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 1995;76:720-6. [PMID: 8625172 DOI: 10.1002/1097-0142(19950901)76:5<720::aid-cncr2820760503>3.0.co;2-e] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 383 |
Piffkó J, Bánkfalvi A, Ofner D, Berens A, Tkotz T, Joos U, Böcker W, Schmid KW. Expression of p53 protein in oral squamous cell carcinomas and adjacent non-tumorous mucosa of the floor of the mouth: an archival immunohistochemical study using wet autoclave pretreatment for antigen retrieval. J Oral Pathol Med 1995;24:337-42. [PMID: 7500288 DOI: 10.1111/j.1600-0714.1995.tb01196.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 384 |
Dursun G, Sak SD, Akyol G, Dursun A, Erekul S, Demireller A, Akiner M. Overexpression of p53 in Laryngeal Carcinoma: Clinicopathological Implications. Ear Nose Throat J 1995;74:645-8. [DOI: 10.1177/014556139507400911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 385 |
Sauter G, Moch H, Gasser TC, Mihatsch MJ, Waldman FM. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. Cytometry 1995;21:40-6. [PMID: 8529469 DOI: 10.1002/cyto.990210109] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 386 |
Danks RA, Chopra G, Gonzales MF, Orian JM, Kaye AH. Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma. Neurosurgery 1995;37:246-54. [PMID: 7477776 DOI: 10.1227/00006123-199508000-00009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 387 |
Thor A. Editorial comments: Detection of abnormal p53 protein levels in cytology specimens: Present and future applications. Diagn Cytopathol 1995;13:132-133. [DOI: 10.1002/dc.2840130210] [Reference Citation Analysis]
|
| 388 |
Ellison DW, Steart PV, Gatter KC, Weller RO. Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. Neuropathol Appl Neurobiol 1995;21:352-61. [PMID: 7494604 DOI: 10.1111/j.1365-2990.1995.tb01070.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 52] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 389 |
Danks RA, Chopra G, Gonzales MF, Orian JM, Kaye AH. Aberrant p53 Expression Does Not Correlate with the Prognosis in Anaplastic Astrocytoma: . Neurosurgery 1995;37:246???254. [DOI: 10.1097/00006123-199508000-00009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 390 |
Hupp TR, Lane DP. Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner. J Biol Chem 1995;270:18165-74. [PMID: 7629129 DOI: 10.1074/jbc.270.30.18165] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 391 |
Lauritzen AF, Vejlsgaard GL, Hou-Jensen K, Ralfkiaer E. p53 protein expression in cutaneous T-cell lymphomas. Br J Dermatol 1995;133:32-6. [PMID: 7669637 DOI: 10.1111/j.1365-2133.1995.tb02488.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 392 |
Walker C, Dixon GR, Myskow M. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J Pathol 1995;176:319-20. [PMID: 7674094 DOI: 10.1002/path.1711760314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 393 |
Sarraf CE, Alison MR, Ansari TW, Wright NA. Subcellular distribution of peptides associated with gastric mucosal healing and neoplasia. Microsc Res Tech 1995;31:234-247. [DOI: 10.1002/jemt.1070310307] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 394 |
Craanen ME, Blok P, Dekker W, Offerhaus GJ, Tytgat GN. Chronology of p53 protein accumulation in gastric carcinogenesis. Gut 1995;36:848-52. [PMID: 7615272 DOI: 10.1136/gut.36.6.848] [Cited by in Crossref: 43] [Cited by in F6Publishing: 50] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 395 |
Lam KY, Loke SL, Chen WZ, Cheung KN, Ma L. Expression of p53 in oesophageal squamous cell carcinoma in Hong Kong Chinese. Eur J Surg Oncol 1995;21:242-7. [PMID: 7781789 DOI: 10.1016/s0748-7983(95)91228-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 396 |
Herrington CS. Human papillomaviruses (HPV) in gynaecological cytology: from molecular biology to clinical testing. Cytopathology 1995;6:176-89. [PMID: 7669929 DOI: 10.1111/j.1365-2303.1995.tb00471.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 397 |
Tilkin AF, Lubin R, Soussi T, Lazar V, Janin N, Mathieu MC, Lefrère I, Carlu C, Roy M, Kayibanda M. Primary proliferative T cell response to wild-type p53 protein in patients with breast cancer. Eur J Immunol 1995;25:1765-9. [PMID: 7615005 DOI: 10.1002/eji.1830250642] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 398 |
Biernat W, Kordek R, Woźniak L. Over-expression of p53 protein as an indicator of the malignant transformation in spiradenoma. Histopathology 1995;26:439-43. [PMID: 7657312 DOI: 10.1111/j.1365-2559.1995.tb00251.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 399 |
Piffko J, Bankfalvi A, Ofner D, Joos U, Böcker W, Schmid KW. Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval. J Pathol 1995;176:69-75. [PMID: 7616359 DOI: 10.1002/path.1711760111] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 400 |
Gorgoulis V, Zoumpourlis V, Rassidakis G, Karameris A, Barbatis C, Spandidos DA, Kittas C. Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index. Virchows Arch 1995;426:339-44. [PMID: 7599785 DOI: 10.1007/BF00191341] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 401 |
Noel JC, Heenen M. Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomaviruses. J Am Acad Dermatol 1995;32:819-20. [PMID: 7722037 DOI: 10.1016/0190-9622(95)91490-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 402 |
Lee CS, Pirdas A. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Pathology 1995;27:117-20. [PMID: 7567135 DOI: 10.1080/00313029500169692] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 403 |
Wang DG, Johnston CF, Anderson N, Sloan JM, Buchanan KD. Overexpression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis. J Pathol 1995;175:397-401. [PMID: 7790993 DOI: 10.1002/path.1711750406] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 404 |
Pizarro A, Gamallo C, Castresana JS, Gomez L, Palacios J, Benito N, Espada J, Fonseca E, Contreras F. p53 protein expression in viral warts from patients with epidermodysplasia verruciformis. Br J Dermatol 1995;132:513-9. [PMID: 7748739 DOI: 10.1111/j.1365-2133.1995.tb08704.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 405 |
Ellison DW, Lunec J, Gallagher PJ, Steart PV, Jaros E, Gatter KC. Accumulation of wild-type p53 in meningiomas. Neuropathol Appl Neurobiol 1995;21:136-42. [PMID: 7609844 DOI: 10.1111/j.1365-2990.1995.tb01040.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 406 |
Heatley M. Distribution of cervical intraepithelial neoplasia: are hysterectomy specimens sampled appropriately? J Clin Pathol 1995;48:323-4. [PMID: 7615850 DOI: 10.1136/jcp.48.4.323] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 407 |
Langlois NE, King G, Herriot R, Thompson WD. An evaluation of the staining of lymphomas and normal tissues by the rabbit polyclonal antibody to protein gene product 9.5 following non-enzymatic retrieval of antigen. J Pathol 1995;175:433-9. [PMID: 7540685 DOI: 10.1002/path.1711750411] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 408 |
Digiuseppe JA, Hruban RH. Pathobiology of cancer of the pancreas. Semin Surg Oncol 1995;11:87-96. [DOI: 10.1002/ssu.2980110203] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 409 |
Wright C, Thomas D, Mellon K, Neal DE, Horne CH. Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index. Br J Urol 1995;75:173-9. [PMID: 7850321 DOI: 10.1111/j.1464-410x.1995.tb07306.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 410 |
Xerri L, Parc P, Bouabdallah R, Camerlo J, Hassoun J. PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease. J Pathol 1995;175:189-94. [PMID: 7738714 DOI: 10.1002/path.1711750206] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 411 |
MacGrogan G, Bonichon F, de Mascarel I, Trojani M, Durand M, Avril A, Coindre JM. Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases. Breast Cancer Res Treat 1995;36:71-81. [PMID: 7579509 DOI: 10.1007/BF00690187] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 412 |
Regezi JA, Zarbo RJ, Regev E, Pisanty S, Silverman S, Gazit D. p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas. J Oral Pathol Med 1995;24:18-22. [PMID: 7722917 DOI: 10.1111/j.1600-0714.1995.tb01124.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 413 |
Ojanguren I, Ariza A, Castellà EM, Fernández-Vasalo A, Mate JL, Navas-Palacios JJ. p53 immunoreactivity in hepatocellular adenoma, focal nodular hyperplasia, cirrhosis and hepatocellular carcinoma. Histopathology 1995;26:63-8. [PMID: 7713485 DOI: 10.1111/j.1365-2559.1995.tb00622.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 414 |
Diamandis EP, Levesque MA. Assessment of p53 overexpression by non-immunohistochemical methods. J Pathol 1995;175:93-5. [PMID: 7891232 DOI: 10.1002/path.1711750114] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 415 |
Dix BR, Robbins P, Soong R, Jenner D, House AK, Iacopetta BJ. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int J Cancer 1994;59:747-51. [PMID: 7989112 DOI: 10.1002/ijc.2910590606] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 416 |
Takata M, Matsui Y. Proliferating cell nuclear antigen (PCNA) and p53 protein expression in Bowen's disease. J Dermatol 1994;21:947-52. [PMID: 7868767 DOI: 10.1111/j.1346-8138.1994.tb03317.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 417 |
Kerr KM, Carey FA, King G, Lamb D. Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression. J Pathol 1994;174:249-56. [PMID: 7884586 DOI: 10.1002/path.1711740404] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 418 |
Vijeyasingam R, Darnton SJ, Jenner K, Allen CA, Billingham C, Matthews HR. Expression of p53 protein in oesophageal carcinoma: clinicopathological correlation and prognostic significance. Br J Surg 1994;81:1623-6. [PMID: 7827889 DOI: 10.1002/bjs.1800811120] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 419 |
Fontanini G, Vignati S, Bigini D, Merlo GR, Ribecchini A, Angeletti CA, Basolo F, Pingitore R, Bevilacqua G. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J Pathol 1994;174:23-31. [PMID: 7965400 DOI: 10.1002/path.1711740105] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 420 |
Tan SH, Derrick E, McKee PH, Hobbs C, Ridley M, Neill S. Altered p53 expression and epidermal cell proliferation is seen in vulval lichen sclerosus. J Cutan Pathol 1994;21:316-23. [PMID: 7798388 DOI: 10.1111/j.1600-0560.1994.tb00706.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 421 |
Symmans PJ, Linehan JM, Brito MJ, Filipe MI. p53 expression in Barrett's oesophagus, dysplasia, and adenocarcinoma using antibody DO-7. J Pathol 1994;173:221-6. [PMID: 7931842 DOI: 10.1002/path.1711730304] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 422 |
Dowell SP, Hall PA. The clinical relevance of the p53 tumour suppressor gene. Cytopathology 1994;5:133-45. [PMID: 7919056 DOI: 10.1111/j.1365-2303.1994.tb00409.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 423 |
Johnston SR, MacLennan KA, Sacks NP, Salter J, Smith IE, Dowsett M. Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen. Eur J Cancer 1994;30A:1663-9. [PMID: 7833141 DOI: 10.1016/0959-8049(94)00327-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 1.6] [Reference Citation Analysis]
|
